<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001921" GROUP_ID="STROKE" ID="148299081711283945" MERGED_FROM="" MODIFIED="2008-08-25 11:32:05 +0200" MODIFIED_BY="Hazel Fraser" REVIEW_NO="0001" REVMAN_SUB_VERSION="5.0.15" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="4.0">
<COVER_SHEET MODIFIED="2008-08-25 11:32:05 +0200" MODIFIED_BY="Hazel Fraser">
<TITLE>Eversion versus conventional carotid endarterectomy for preventing stroke</TITLE>
<CONTACT MODIFIED="2008-08-25 11:32:05 +0200" MODIFIED_BY="Hazel Fraser"><PERSON ID="9227" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Piergiorgio</FIRST_NAME><LAST_NAME>Cao</LAST_NAME><POSITION>Chief of Vascular Surgery</POSITION><EMAIL_1>pcao@unipg.it</EMAIL_1><ADDRESS><DEPARTMENT>Unita' Operativa di Chirurgia Vascolare</DEPARTMENT><ORGANISATION/><ADDRESS_1>Via Brunamonti</ADDRESS_1><CITY>Perugia</CITY><ZIP>06122</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 75 5732876</PHONE_1><PHONE_2>+39 75 5783972</PHONE_2><FAX_1>+39 75 5783194</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-08-25 11:32:05 +0200" MODIFIED_BY="Hazel Fraser"><PERSON ID="9227" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Piergiorgio</FIRST_NAME><LAST_NAME>Cao</LAST_NAME><POSITION>Chief of Vascular Surgery</POSITION><EMAIL_1>pcao@unipg.it</EMAIL_1><ADDRESS><DEPARTMENT>Unita' Operativa di Chirurgia Vascolare</DEPARTMENT><ORGANISATION/><ADDRESS_1>Via Brunamonti</ADDRESS_1><CITY>Perugia</CITY><ZIP>06122</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 75 5732876</PHONE_1><PHONE_2>+39 75 5783972</PHONE_2><FAX_1>+39 75 5783194</FAX_1></ADDRESS></PERSON><PERSON ID="16456" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Paola</FIRST_NAME><LAST_NAME>De Rango</LAST_NAME><EMAIL_1>pderango@unipg.it</EMAIL_1><ADDRESS><DEPARTMENT>Unita' Operativa di Chirurgia Vascolare</DEPARTMENT><ORGANISATION/><ADDRESS_1>Via Brunamonti</ADDRESS_1><CITY>Perugia</CITY><ZIP>06122</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 075 5732876</PHONE_1><PHONE_2>+39 075 5783972</PHONE_2><FAX_1>+39 075 5783194</FAX_1></ADDRESS></PERSON><PERSON ID="16564" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Simona</FIRST_NAME><LAST_NAME>Zannetti</LAST_NAME><POSITION>Clinical Study Manager</POSITION><EMAIL_1>zannetti@unipg.it</EMAIL_1><ADDRESS><DEPARTMENT>Peripheral Vascular Division</DEPARTMENT><ORGANISATION>Medtronic-Europe</ORGANISATION><ADDRESS_1>Via Brunamonti</ADDRESS_1><CITY>Perugia</CITY><ZIP>06122</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 075 5732876</PHONE_1><PHONE_2>+39 075 5783972</PHONE_2><FAX_1>+39 075 5783194</FAX_1></ADDRESS></PERSON><PERSON ID="16479" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Giuseppe</FIRST_NAME><LAST_NAME>Giordano</LAST_NAME><EMAIL_1>ggiordano@unipg.it</EMAIL_1><ADDRESS><DEPARTMENT>Unita' Operativa di Chirurgia Vascolare</DEPARTMENT><ORGANISATION/><ADDRESS_1>Via Brunamonti</ADDRESS_1><CITY>Perugia</CITY><ZIP>06122</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 075 5732876</PHONE_1><PHONE_2>+39 075 5783972</PHONE_2><FAX_1>+39 075 5783194</FAX_1></ADDRESS></PERSON><PERSON ID="6345" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Stefano</FIRST_NAME><LAST_NAME>Ricci</LAST_NAME><EMAIL_1>istitaly@unipg.it</EMAIL_1><ADDRESS><DEPARTMENT>Servizio di Neurologia e Ictus</DEPARTMENT><ORGANISATION>USL 2</ORGANISATION><ADDRESS_1>Via Cestellini</ADDRESS_1><CITY>Perugia</CITY><REGION>06087</REGION><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 0755978109</PHONE_1><PHONE_2>+39 0755978127</PHONE_2><FAX_1>+39 0755978110</FAX_1></ADDRESS></PERSON><PERSON ID="6193" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Maria Grazia</FIRST_NAME><LAST_NAME>Celani</LAST_NAME><EMAIL_1>istitaly@unipg.it</EMAIL_1><ADDRESS><DEPARTMENT>Servizio di Neurologia e Ictus</DEPARTMENT><ORGANISATION>USL 2</ORGANISATION><ADDRESS_1>Via Cestellini </ADDRESS_1><CITY>Perugia</CITY><ZIP>06087</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 75 5978109 </PHONE_1><FAX_1>+39 75 5978110 </FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-08-19 15:30:27 +0100" MODIFIED_BY="Hazel Fraser">
<UP_TO_DATE>
<DATE DAY="26" MONTH="5" YEAR="2003"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="28" MONTH="7" YEAR="2002"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2001"/>
</DATES>
<WHATS_NEW MODIFIED="2008-08-19 15:31:42 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="19" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-08-19 15:33:13 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-08-19 15:33:13 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="26" MONTH="5" YEAR="2003"/>
<DESCRIPTION>
<P>No substantive amendment was possible because no new recent randomised studies have been published. Because a number of non-randomised studies have been recently performed on this topic, new references have been added in the Additional references section and in the Background of the review.<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-08-20 12:13:29 +0100" MODIFIED_BY="Hazel Fraser">
<SUMMARY MODIFIED="2008-08-20 11:50:30 +0100" MODIFIED_BY="Hazel Fraser">
<TITLE MODIFIED="2008-08-19 15:34:06 +0100" MODIFIED_BY="Hazel Fraser">Eversion versus conventional carotid endarterectomy for preventing stroke</TITLE>
<SUMMARY_BODY MODIFIED="2008-08-20 11:50:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>There is not enough evidence to decide the best way to do the operation of carotid endarterectomy (CEA) to prevent stroke. The carotid artery is one of the main arteries in the neck supplying blood to the brain. A blockage in the artery can cause a stroke (a sudden catastrophe in the brain either because an artery to the brain blocks, or because an artery in or on the brain ruptures and bleeds). CEA involves two different methods to clear the artery. This is done by either eversion (oblique division of the internal carotid artery at its origin, removing the blockage through this access and reimplantation (re-joining) of the vessel at the same original level) or conventional CEA (longitudinal opening of the artery followed by removal of the blockage and suture with or without an enlargement patch). The review found that there was not enough evidence to show either the benefits or adverse effects of these two methods. Eversion CEA may lower the risk of restenosis (renarrowing) of the artery but more research is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-08-20 11:49:59 +0100" MODIFIED_BY="Hazel Fraser">
<ABS_BACKGROUND>
<P>Carotid endarterectomy (CEA) is conventionally undertaken by a longitudinal arteriotomy. Eversion CEA, which employs a transverse arteriotomy and reimplantation of the carotid artery, is reported to be associated with low perioperative stroke and restenosis rates but an increased risk of complications associated with a distal intimal flap.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-08-19 15:43:59 +0100" MODIFIED_BY="Hazel Fraser">
<P>To determine whether eversion CEA was safe and more effective than conventional CEA. The null-hypothesis was that there was no difference between the eversion and the conventional CEA techniques (performed either with primary closure or patch angioplasty).</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-08-19 15:44:54 +0100" MODIFIED_BY="Hazel Fraser">
<P>We searched the Cochrane Stroke Group Trials Register (last searched July 2002), the Cochrane Central Register of Controlled Trials (<I>The Cochrane Librar</I>y 2002, Issue 4), MEDLINE (1966 to December 2002) and EMBASE (1980 to December 2002). In addition, eight surgical journals were handsearched and researchers were contacted to identify additional published and unpublished studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All randomised trials comparing eversion to conventional techniques in patients undergoing carotid endarterectomy were examined in this review. Outcomes were stroke and death, carotid restenosis/occlusion, and local complications.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-08-19 15:45:21 +0100" MODIFIED_BY="Hazel Fraser">
<P>Data were extracted independently by two reviewers to assess eligibility and describe trial characteristics, and by one reviewer for meta-analyses. When possible, unpublished data were obtained from investigators.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-08-20 11:49:59 +0100" MODIFIED_BY="Hazel Fraser">
<P>Five trials were included for a total of 2465 patients and 2589 arteries. Three trials included bilateral carotid endarterectomies. In one trial, arteries rather than patients were randomised so that it was not clear how many patients had been randomised in each group, therefore, information on the risk of stroke and death from this study were considered in a separate analysis. There were no significant differences in the rate of perioperative stroke and/or death (1.7% versus 2.6%, odds ratio (OR) 0.44, 95% confidence interval (CI) 0.10 to 1.82) and stroke during follow up (1.4% versus 1.7%, Peto OR 0.84, 95% CI 0.43 to 1.64) between eversion and conventional CEA techniques. Eversion CEA was associated with a significantly lower rate of restenosis &gt; 50% during follow up (2.5% versus 5.2%, Peto OR 0.48, 95% CI 0.32 to 0.72). However, there was no evidence that the eversion technique for CEA was associated with a lower rate of neurological events when compared to conventional CEA. There were no statistically significant differences in local complications between the eversion and conventional group. No data were available to define the cost-benefit of eversion CEA technique.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Eversion CEA may be associated with low risk of arterial occlusion and restenosis. However, numbers are too small to definitively assess benefits or harms. Reduced restenosis rates did not appear to be associated with clinical benefit in terms of reduced stroke risk, either perioperatively or later. Until further evidence is available, the choice of the CEA technique should depend on the experience and familiarity of the individual surgeon.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-20 12:12:01 +0100" MODIFIED_BY="Hazel Fraser">
<BACKGROUND MODIFIED="2008-08-20 11:51:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>In the last few decades carotid endarterectomy (CEA) has undergone intensive evaluation, criticism, and subsequent acceptance as an effective method for stroke prevention (<LINK REF="REF-ECST-1991" TYPE="REFERENCE">ECST 1991</LINK>; <LINK REF="REF-NASCET-1991" TYPE="REFERENCE">NASCET 1991</LINK>; <LINK REF="REF-ACAS-1995" TYPE="REFERENCE">ACAS 1995</LINK>; <LINK REF="REF-ECST-1998" TYPE="REFERENCE">ECST 1998</LINK>; <LINK REF="REF-NASCET-1998" TYPE="REFERENCE">NASCET 1998</LINK>). Indications for CEA have been defined, outcomes have markedly improved, and technical aspects have evolved significantly. However, the ideal surgical technique to optimise early outcome and long-term durability of CEA has yet to be determined.</P>
<P>The most frequently employed technique for CEA is conventional CEA, performed through a longitudinal arteriotomy of the internal carotid artery. Eversion endarterectomy of the carotid artery was initially reported by DeBakey et al and later described by Etheredge (<LINK REF="REF-DeBakey-1959" TYPE="REFERENCE">DeBakey 1959</LINK>; <LINK REF="REF-Etheredge-1970" TYPE="REFERENCE">Etheredge 1970</LINK>). This technique is performed through a transverse rather than a longitudinal arteriotomy, thus the artery is less prone to restenosis, particularly when sutures are placed at the widest part of the artery (i.e. common carotid artery or the base of the carotid bulb). The reported perioperative major complication rate in patients undergoing eversion CEA, as part of non-randomised case series, ranges from 1% to 4% (<LINK REF="REF-Berguer-1993" TYPE="REFERENCE">Berguer 1993</LINK>; <LINK REF="REF-Cao-1997" TYPE="REFERENCE">Cao 1997</LINK>; <LINK REF="REF-Darling-III-1996" TYPE="REFERENCE">Darling III 1996</LINK>; <LINK REF="REF-Entz-1996" TYPE="REFERENCE">Entz 1996</LINK>; <LINK REF="REF-Raithel-1993" TYPE="REFERENCE">Raithel 1993</LINK>; <LINK REF="REF-Kieny-1993" TYPE="REFERENCE">Kieny 1993</LINK>; <LINK REF="REF-Reigner-1995" TYPE="REFERENCE">Reigner 1995</LINK>; <LINK REF="REF-Vanmaele-1990" TYPE="REFERENCE">Vanmaele 1990</LINK>; <LINK REF="REF-Shah-1998" TYPE="REFERENCE">Shah 1998</LINK>; <LINK REF="REF-Peiper-1999" TYPE="REFERENCE">Peiper 1999</LINK>; <LINK REF="REF-Economopoulos-1999" TYPE="REFERENCE">Economopoulos 1999</LINK>; <LINK REF="REF-Raftopoulos-2000" TYPE="REFERENCE">Raftopoulos 2000</LINK>; <LINK REF="REF-Chang-2000" TYPE="REFERENCE">Chang 2000</LINK>; <LINK REF="REF-Green-2000" TYPE="REFERENCE">Green 2000</LINK>; <LINK REF="REF-Radak-2000" TYPE="REFERENCE">Radak 2000</LINK>; <LINK REF="REF-Katras-2001" TYPE="REFERENCE">Katras 2001</LINK>; <LINK REF="REF-Mehta-2001" TYPE="REFERENCE">Mehta 2001</LINK>). Long-term risk of recurrent stenosis is low, about 1% over five years (<LINK REF="REF-Koskas-1995" TYPE="REFERENCE">Koskas 1995</LINK>). However, if not performed properly, there is the possibility that a distal intimal flap may remain, with potentially dangerous consequences.</P>
<P>Carotid restenosis after conventional CEA has been reported in 6% to 36% of patients; the reported risk of symptomatic restenosis ranges from 2% to 4%. The majority of carotid restenosis occur between three and 18 months after surgery (<LINK REF="REF-Frericks-1998" TYPE="REFERENCE">Frericks 1998</LINK>; <LINK REF="REF-Moore-1998" TYPE="REFERENCE">Moore 1998</LINK>). Although the relationship between carotid restenosis and risk of stroke is still unclear, reduction in restenosis rates may decrease the need for restenosis-related procedures (diagnostic and therapeutic), patients' management, and costs.</P>
<P>There is still much controversy about the relative benefits of the different surgical techniques for CEA. To date there are no systematic reviews on this topic.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-08-20 11:51:58 +0100" MODIFIED_BY="Hazel Fraser">
<P>To determine efficacy and safety of eversion CEA technique with respect to conventional technique for CEA. The null-hypothesis was that there was no difference between the eversion and the conventional CEA technique (performed either with primary closure or patch angioplasty) with respect to:<BR/>
</P>
<UL>
<LI>stroke and death;</LI>
<LI>carotid restenosis and carotid occlusion;</LI>
<LI>risk of local complications;</LI>
<LI>procedure-related costs (if available).</LI>
</UL>
</OBJECTIVES>
<METHODS MODIFIED="2008-08-20 11:59:52 +0100" MODIFIED_BY="Hazel Fraser">
<SELECTION_CRITERIA MODIFIED="2008-08-20 11:57:57 +0100" MODIFIED_BY="Hazel Fraser">
<CRIT_STUDIES MODIFIED="2008-08-20 11:54:21 +0100" MODIFIED_BY="Hazel Fraser">
<P>The aim was to identify and analyse randomised controlled trials (RCTs), i.e. trials comparing eversion to conventional CEA, employing true randomisation or quasi-randomisation methods (in quasi-randomised trials, the criteria for allocating type of treatment were not strictly random but based on factors such as patient's date of birth, hospital record number, alternation, etc), published or unpublished.</P>
<P>To prevent sampling bias and biased planned treatment, uncontrolled studies or trials in which the criteria for allocation of treatment was not clear were excluded.</P>
<P>True randomised and quasi-randomised controlled trials were combined in the analysis.</P>
<P>Studies were included when:<BR/>
</P>
<UL>
<LI>patient follow up was included;</LI>
<LI>the surgical operation performed was conventional (longitudinal arteriotomy closed by patch or primary closure) or eversion (carotid transection and reimplantation through transverse suture line) CEA;</LI>
<LI>follow up was systematic and not performed only in the case of symptoms;</LI>
<LI>patients (and carotid arteries) were followed up with clinical and/or imaging techniques (i.e. duplex scan).</LI>
</UL>
<P>Studies were excluded when:<BR/>
</P>
<UL>
<LI>focused on combined carotid surgery only (i.e. CEA and coronary artery bypass grafting (CABG) or CEA plus peripheral vascular surgical repair);</LI>
<LI>the carotid bifurcation was completely resected and replaced by a graft;</LI>
<LI>only external carotid artery endarterectomies were performed;</LI>
<LI>epiaortic vessels different from the internal carotid artery were involved (i.e. the subclavian or common carotid arteries).</LI>
</UL>
<P>The following variables were considered essential in determining the risk of outcomes and were extracted from each trial:<BR/>
</P>
<UL>
<LI>number of patients and arteries at risk;</LI>
<LI>number of patients and arteries with restenosis;</LI>
<LI>number of patients with stroke and death after CEA;</LI>
<LI>average follow-up time;</LI>
<LI>definition of restenosis.</LI>
</UL>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Patients of all ages and either gender with carotid stenosis undergoing CEA were considered eligible for inclusion. Patients were included regardless of the degree of carotid stenosis and whether the initial indication for endarterectomy was symptomatic or asymptomatic carotid stenosis.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Eversion carotid technique for CEA versus standard technique for CEA performed with primary closure or patch carotid angioplasty.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-08-20 11:57:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcome measures had been defined by the trial authors.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>(1) All strokes and/or deaths occurred perioperatively (within 30 days of operation)<BR/>(2) Carotid restenosis or occlusion, early or during follow up</P>
<P>Strokes were classified as disabling or non-disabling (as defined by trial authors), fatal or non-fatal, contralateral, ipsilateral, brainstem, haemorrhage, or infarct.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>(1) Any perioperative stroke (within 30 days of operation)<BR/>(2) Perioperative disabling strokes (within 30 days of operation)<BR/>(3) Perioperative ipsilateral strokes (within 30 days of operation)<BR/>(4) Perioperative cardiac events (within 30 days of operation)<BR/>(5) All strokes during the follow-up period and perioperative deaths<BR/>(6) Local complications, perioperative (within 30 days) or later (e.g. cranial nerve injuries, rupture of the artery, infection, pseudoaneurysm formation)<BR/>(7) Duration of operation, length of hospital stay, and procedure-related costs (if data were available)</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-19 15:54:51 +0100" MODIFIED_BY="Hazel Fraser">
<P>Relevant trials were identified in the Cochrane Stroke Group Trials Register. The Register was last searched by the Trials Register Administrator on 29 July 2002.</P>
<P>(1) We also searched the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I>, 2002 Issue 4) and MEDLINE (1966 to December 2002) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), and EMBASE (1980 to December 2002) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
<P>(2) We carried out systematic handsearching of available volumes of the following journals:</P>
<UL>
<LI>
<I>American Journal of Surgery</I> (1990 to December 2002);</LI>
<LI>
<I>Annals of Surgery</I> (1990 to December 2002);</LI>
<LI>
<I>Annals of Vascular Surgery</I> (1992 to December 2002);</LI>
<LI>
<I>British Journal of Surgery </I>(1990 to December 2002);</LI>
<LI>
<I>European Journal of Vascular and Endovascular Surgery</I> (1995 to December 2002);</LI>
<LI>
<I>Giornale Italiano di Chirurgia Vascolare</I> (1990 to December 2002);</LI>
<LI>
<I>Journal of Vascular Surgery </I>(1989 to December 2002);</LI>
<LI>
<I>Surgery</I> (1990 to December 2002).</LI>
</UL>
<P>(3) Specialists currently involved in research were contacted and asked to review the list of identified trials and provide details of additional trials they knew of.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-08-20 11:59:52 +0100" MODIFIED_BY="Hazel Fraser">
<P>Trial selection for inclusion in this review was carried out independently by two reviewers (PDR, SZ). One reviewer identified all trials of possible relevance and forwarded them to the second reviewer. Selected studies underwent independent assessment by both reviewers. The reviewers decided which trials were suitable and evaluated the methodological quality. Discrepancies were resolved by discussion. The two reviewers independently extracted and analysed data from the trials included. No score system was used to assess quality. The following items were evaluated:</P>
<UL>
<LI>method of randomisation (i.e. generation of the randomised sequence and concealment of the random sequence from physicians participating in the trial);</LI>
<LI>blinding of the assessment (duplex and clinical);</LI>
<LI>number of patients lost to follow up;</LI>
<LI>number of patients initially randomised but subsequently not included in the analysis (i.e. cross-over and withdrawn) were recorded for estimation of quality adequacy.</LI>
</UL>
<P>When any of the above details were not available from the published report, the authors were contacted directly either by mail or telephone to obtain further information.</P>
<P>Journal articles that reported patient data used in previous studies from the same Institution were excluded, except when in the methods section it was absolutely clear that patients did not overlap, or when methodology and outcomes were different among studies.</P>
<P>In patients with outcome events allocated according to type of treatment (eversion or conventional CEA), an intention-to-treat analysis, regardless of compliance with the planned treatment, was attempted.</P>
<SUBSECTION>
<HEADING LEVEL="3">Data analysis</HEADING>
<P>For each specified outcome, a pooled estimate of treatment effects (odds ratio for binary outcomes) through the studies was calculated. The statistical package, RevMan, provided by the Cochrane Collaboration was used. We tested heterogeneity between trials using a standard Chi-squared test. A significance level less than 0.05 was interpreted as evidence of heterogeneity. Depending on the presence or absence of RCT variability, a random-effects model or a fixed model (Peto) was used. Odds ratios (OR) and 95% confidence intervals (CI) of homogeneous dichotomous data were calculated by the Peto method and the results were pooled using a fixed-effect model. A random-effects model was used for heterogeneous dichotomous data.</P>
<P>In the presence of significant heterogeneity, sensitivity analysis was planned based on the quality of the trials (allocation concealment, blinding, or sample size calculation).</P>
<P>Truly randomised and quasi-randomised controlled trials were combined in the analysis.</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-08-20 12:10:51 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY_DESCRIPTION MODIFIED="2008-08-20 12:00:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Six trials that achieved eligibility criteria for inclusion in the review were identified. One of these had been published as an abstract (<LINK REF="STD-Darling-1995" TYPE="STUDY">Darling 1995</LINK>) and was excluded. After clarification with the principal investigator, it became clear that this trial was planned with a randomised design; however, randomisation was discontinued and the study proceeded in a prospective non-randomised fashion. The randomised phase of this study could provide information on primary and secondary end-points considered in our review. Yet, a significant amount of data was missing. The author was contacted but data are no longer available for inclusion.</P>
<P>Five trials comparing conventional carotid endarterectomy to eversion carotid endarterectomy (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>; <LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) were included in this review. Two reports were from the same trial referring to early and late results (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>). Two separate randomised trials by Ballotta were included: one (<LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>) included only patients requiring bilateral carotid endarterectomies. Patients were randomised to be treated with staged different techniques for CEA on each side: eversion followed by contralateral patch or patch followed by contralateral eversion CEA. Some patients in this study had been recruited also in the larger randomised trial by the same author included in this review (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>). To avoid that overlapping of patients which could influence the results of the review, we contacted the principal investigator of these trials. Correspondence with the author provided us with the exact number of patients (eighteen) and related outcome events already included in the previous study, and these were excluded, leading 68 patients in the analysis. Therefore, the results displayed in this review differ from those shown in the published report by the author.</P>
<P>For the purposes of this review, we considered only events occurring ipsilateral to the operated carotid artery.</P>
<P>All trials included in the review had two arms of randomisation: eversion and conventional CEA techniques. In the EVEREST trial (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) the eversion technique was compared to both primary closure and patch angioplasty techniques for conventional carotid endarterectomy. In the study by Vanmaele et al (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>) the eversion technique was compared to saphenous vein patch angioplasty. In three studies only synthetic patch, dacron (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>) or polytetrafluoroethylene (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>), was considered for comparison with the eversion technique.</P>
<P>In the study by Vanmaele two different types of eversion technique (retrograde endarterectomy and eversion division endarterectomy anastomosis) were employed (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-08-20 12:02:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>There were some methodological flaws in the included trials. Four studies used a list of random-generated numbers (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>). In three of these, sealed envelopes were employed for randomisation (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>). However, only in one study (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) was it clear from the published report that patient allocation was performed with the use of sequentially numbered sealed envelopes. Correspondence with the investigators of the other studies confirmed that sequentially numbered opaque envelopes were used in two studies (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>) but not in the other (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>). The method of concealment of allocation was unknown in one trial (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>).</P>
<P>In the EVEREST (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) and Balzer (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>) trials sample size calculations were used to manage the conduct of the study.</P>
<P>With respect to blinding in the assessment of outcome events, duplex evaluation in follow up was performed only in three trials by operators blinded to the initial treatment allocation (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>). However, due to the different morphology of the operated arteries in each treatment group (eversion or synthetic patch), complete blinding was impossible.</P>
<P>With respect to blinding in the post-operative clinical assessment, in four trials (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>, <LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>) an independent auditor, such as a neurologist or ophthalmologist, evaluated patients. Instead, in the Balzer trial, clinical assessment and follow up were performed by the operating surgeon (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>).</P>
<P>One of the main flaws in three of the trials was that a patient undergoing bilateral CEA could be randomised twice and have the two carotid arteries randomised to different treatment groups (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>), so that the same patient could be exposed twice to risk.</P>
<P>In the EVEREST trial (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) patients were randomised once. In the study by Balzer (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>), correspondence with the author clarified that, in case of bilateral CEA, only the first operation was considered for randomisation and the same CEA technique was performed on both sides. In three trials, patients undergoing bilateral CEA were included so that the same patients could be exposed twice to risk (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>; <LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>). Fortunately, the number of bilateral procedures was low (124/2589, 4.7% of the total). In the studies by Ballotta et al (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>), the exact number of randomised patients for each arm was specified in the published report. In the other study (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>), the number of arteries randomised to each arm was available, yet it was not clear how many patients (as opposed to arteries) were randomised to each treatment group because 30/170 patients had undergone bilateral procedures. In this trial there was little information on patient risk for any stroke and death. Therefore, the study was excluded from the main analyses of clinical events of our review. However, we believe it is reasonable to include the study in a separate analysis of clinical outcomes (stroke, death, ipsilateral stroke).</P>
<P>Some differences were found in the definition of stroke. In two studies (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>; <LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>) only permanent neurological deficits were considered, whereas in three other studies (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>) all neurological deficits lasting more than 24 hours were reported as 'any stroke'.</P>
<P>Although local complications such as cranial nerve lesions were reported in most studies, not all considered these as outcome events, therefore there was no systematic evaluation of these lesions.</P>
<P>Mean age of patients was 68 years (range 38 to 92 years) and male patients were two times more frequent than females. All trials included patients with symptomatic and asymptomatic carotid disease. The percentage of asymptomatic patients between the eversion and conventional groups in all studies were similar.</P>
<P>There was no imbalance in the rates of risk factors between the eversion and conventional groups in all the examined studies.</P>
<P>In one study, 'in hospital' rather than 'perioperative' events were reported (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>). However, because late data were also reported separately, information regarding the whole perioperative period (within 30 days after surgery) was obtained.</P>
<P>Follow up ranged from one to 69 months. Overall, 33 patients were lost to follow up: 20 in the eversion group and 13 in the conventional group.</P>
<P>Two studies had patients who crossed over from one treatment arm to the other (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>). Twenty-two of 24 overall crossover patients were from the EVEREST study and data were available for intention-to-treat analysis.</P>
<P>Further details on the included studies are shown in the table on 'Characteristics of Included Studies'.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-08-20 12:10:51 +0100" MODIFIED_BY="Hazel Fraser">
<SUBSECTION>
<HEADING LEVEL="3">Outcomes included</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Perioperative stroke and/or death (Figure 1)</HEADING>
<P>Four trials were eligible for the analysis (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>; <LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>). The cumulative unweighted risk of stroke and/or death within 30 days of surgery was low ( 2.1%): 51 events were recorded, 20 events were found in the eversion CEA group and 31 in the conventional CEA group (OR 0.44, 95% CI 0.10 to 1.82). No definite conclusions could be drawn.</P>
<P>Significant heterogeneity was found among the results of the trials in this outcome; sensitivity analyses were performed (see Figures 9 and 10). This variability could be due to the fact that in the smallest trials (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>) all operations were performed by a single surgeon and sample size of the study population had not been calculated. In fact, significant heterogeneity disappeared when these small studies were not taken into account (Figure 9).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Perioperative death (Figure 2)</HEADING>
<P>There were 15 perioperative deaths in the four trials eligible for this analysis (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) - seven in the eversion CEA and eight in the conventional CEA group. No definite conclusions can be drawn on whether conventional CEA is associated with higher or lower perioperative death than eversion CEA (Peto OR 0.86, 95% CI 0.31 to 2.37). Five perioperative deaths, four in the eversion CEA and one in the conventional CEA group, were stroke-related.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Any perioperative stroke (Figures 3 to 6)</HEADING>
<P>The number of perioperative strokes was available in four trials. Forty-one perioperative strokes (fatal, non-fatal, contralateral, ipsilateral brainstem, haemorrhage, or infarct) were recorded: 17 in the eversion group and 24 in the conventional group. The benefits or hazards of eversion CEA in perioperative stroke risk from these data remains unclear (Peto OR 0.70; 95% CI 0.38 to 1.29).</P>
<P>In all of the trials available the absolute risks of perioperative stroke were low irrespective of treatment: 41/2363 (1.7%). Furthermore, the risk of perioperative stroke was particularly low in the small trials (i.e. excluding the EVEREST trial), especially in the eversion group. A possible influence on these results could be the lack of blinding in one of the small studies (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>) in which post-operative clinical assessment was performed by the surgeon and not by an independent audit. Furthermore, in two other small trials (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>) all operations were performed by a single surgeon and sample size of the study population had not been calculated. These methodological flaws could have biased the results in small trials. Sensitivity analyses were performed (Figures 4 to 6).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Any perioperative disabling stroke (Figure 7)</HEADING>
<P>Four trials (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) provided data on perioperative disabling stroke risk: 25 perioperative major strokes were recorded: nine in the eversion group and 16 in the conventional group. Again, the benefits or hazards of eversion CEA were still not clear (Peto OR 0.56, 95% CI 0.25 to 1.23).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Any perioperative ipsilateral stroke (Figure 8)</HEADING>
<P>The overall risk was low (1.6%). There were no significant differences in the risk of perioperative strokes ipsilateral to the operated carotid artery: Peto OR 0.92, 95% CI 0.44 to 1.93.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Perioperative arterial complications occurring within 30 days of surgery (analysed in relation to arteries and not to patients)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Early carotid occlusion (Figure 11)</HEADING>
<P>Four trials reported the risk of early carotid occlusion (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>; <LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>). Overall, 18 carotid occlusion occurred. There was a non-significant trend in favour of eversion CEA (Peto OR 0.62, 95% CI 0.24-1.58). Six early carotid occlusions were associated with fatal or disabling stroke.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Neck hematoma (Figure 12)</HEADING>
<P>Four trials reported the number of neck hematomas requiring surgical re-exploration. No significant differences were observed between the eversion and conventional CEA groups: 4.2% versus 5.5% (Peto OR 0.76, 95% CI 0.52 to 1.11).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cranial nerve injuries (Figure 13)</HEADING>
<P>Based on the available data, risk of cranial nerve lesions after CEA was not negligible (4.7%) and showed a non-significant trend in favour of the eversion technique. Yet, no definite conclusions can be drawn (OR 0.52, 95% CI 0.22 to 1.23).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Perioperative myocardial infarction (within 30 days of surgery) (Figure 14)</HEADING>
<P>Two studies reported data for this outcome (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>). Only nine myocardial infarctions were reported in the perioperative period, so the overall risk was low (0.5%). Due to the small number of events, no definite conclusions can be drawn (Peto OR 0.79, 95% CI 0.21 to 2.92).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Clinical outcomes during late follow up</HEADING>
<P>All the studies had a minimum follow up of one year; a total of 33 patients lost to follow up were recorded.</P>
<SUBSECTION>
<HEADING LEVEL="4">Stroke during follow up (excluding perioperative) (Figure 15)</HEADING>
<P>The overall risk of late stroke based on the three studies (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>) available for the analysis was low (1.6%). If all the patients lost to follow up were assumed to be alive and stroke free, significant uncertainty remains on the benefit in terms of any stroke risk for patients undergoing eversion CEA: 16 late strokes in patients allocated to eversion CEA versus 19 in the conventional CEA group (Peto OR 0.84, 95% CI 0.43 to 1.64).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Ipsilateral stroke during follow up (excluding perioperative) (Figure 16)</HEADING>
<P>There were few late ipsilateral strokes in the two studies eligible for the analysis - nine in the eversion group and four in the conventional group. Due to the small number and wide confidence intervals, no firm conclusions were drawn on the benefit of eversion CEA on the risk of late ipsilateral stroke (Peto OR 2.16, 95% CI 0.73 to 6.45).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Arterial occlusion or restenosis &gt; 50% during follow up (Figures 17 to 22)</HEADING>
<P>Five studies were considered (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>; <LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>; <LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>; <LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>). Perioperative carotid occlusions were excluded from this analysis. All five trials provided data on the number of arteries that became occluded or developed restenosis &gt; 50% (as assessed by duplex ultrasound) by the end of follow up. All studies had a minimum follow up of one year. A total of 33 patients lost to follow up were recorded. As all these patients were randomised only once, 33 arteries were lost to follow up, 20 in the eversion CEA group and 13 in the conventional CEA group.</P>
<P>In the main analysis all arteries lost to follow up were assumed not to have been restenosed or occluded (best clinical scenario; Figure 17). Eversion CEA was associated with a lower risk of carotid occlusion or restenosis (32/1290 versus 66/1267; Peto OR 0.48, 95% CI 0.32 to 0.72). This was equivalent to preventing occlusion or restenosis in about 100 of 3660 operated arteries. However, if all the arteries that were lost to follow up in the eversion group were assumed to have become restenosed while none of those lost to follow up in the conventional group became restenosed (worst scenario; Figure 18), the results became non-significant (OR 0.53, 95% CI 0.17 to 1.69). The clinical significance of this reduction in risk of carotid restenosis/occlusion is unknown.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">All strokes during follow-up period and perioperative deaths (Figure 23)</HEADING>
<P>There were no significant differences between treatment groups: 23 events were found after eversion CEA and 27 after conventional CEA (Peto OR 0.84, 95% CI 0.48 to 1.47). Similarly, no significant differences were found only for strokes occurring ipsilateral to the operated carotid artery during follow up together with perioperative deaths (Figure 24): due to the small number and wide confidence intervals, no firm conclusions were drawn.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Periprocedural costs, duration of operation and of hospital stay</HEADING>
<P>No data are available for the analyses.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis</HEADING>
<P>Sensitivity analyses were performed and the treatment effect still remained when the poorer quality trials were excluded. In detail, it was investigated whether:</P>
<UL>
<LI>trials using adequate concealment in randomisation differed from trials using inadequate concealment methods;</LI>
<LI>trials using more rigorous blinding differed from those with poor blinding assessment;</LI>
<LI>small trials differed from those with large sample size;</LI>
<LI>trials in which sample size had been calculated differed from those without this estimation.</LI>
</UL>
<P>Results are shown in Figures 3, 4, 5, 9, 10, 19, 20, 21 and 22 of the analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Separate subsidiary analyses</HEADING>
<P>(1) Separate analysis of clinical outcomes was performed including also the study in which the number of deaths and strokes was not available on a patient (rather than artery) basis in each allocated treatment group (ie, <LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>). This study had been excluded in calculating patient-related outcome events such as death and any stroke in the main analysis of this review. However, given that relatively few patients had bilateral procedures, we felt it reasonable to include this study in a separate analysis. These results should be interpreted with caution.</P>
<P>No substantial differences were found with respect to the main analysis (see Figures 25 to 30); no definite conclusion can be drawn from these additional data in the benefits (or hazards) of eversion CEA for each of the outcomes analysed.</P>
<P>(2) An additional separate analysis of clinical outcomes was performed excluding the study in which all the patients had undergone bilateral procedures (<LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>). We specifically excluded this study from all the analyses of patient-level effect (death, stroke, etc). However, due to the small number of events reported in this study, no substantial differences were found with respect to the main results of our review. Risk of perioperative stroke and/or death based on this analysis is reported in Figure 31.</P>
<P>Other details of the main and separate analyses are shown.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-08-20 12:12:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Changes in surgical techniques may affect the outcome of CEA. Although encouraging results regarding restenosis rates have been described with eversion CEA, a relative reluctance to perform this technique remains. The results of the present review of five randomised trials suggest that eversion CEA appears to be associated with a similar rate of major clinical outcome events (i.e. perioperative or late stroke) when compared to conventional CEA; however, since these are few in number, significant uncertainty remains.</P>
<P>The unweighted absolute risk of stroke and/or death within 30 days of CEA found in our review was exceptionally low regardless of the type of treatment: 51/2363 (2.1%). This finding could be due to the high proportion, balanced between the treatment groups, of asymptomatic patients in the included studies.</P>
<P>Furthermore, we found that the risk of perioperative stroke was particularly low in the eversion group of small trials. The poor quality of blinding in assessment (and of allocation concealment) of some small trials could have biased the results of this analysis. Therefore, due to the low absolute risk of stroke, our results should be applied with caution to high-risk populations.</P>
<P>An insufficient number of local complications were reported to compare risks associated with eversion and conventional CEA. Similarly, with respect to risk of early carotid occlusion, the data of this review were inconclusive.</P>
<P>A statistically significant decrease in the risk of restenosis and arterial occlusion during follow up in patients undergoing eversion CEA when compared to conventional CEA was observed. This was equivalent to the prevention of about 100 carotid occlusion/restenosis per 3660 operated arteries with eversion technique. However, as yet these results are not statistically robust because of the limited number and the losses to follow up. Yet, if we consider the worst case scenario, i.e. assuming that all eversion CEA procedures lost to follow up were occluded or restenosed, while none were lost in the primary closure group, the difference between eversion and conventional CEA was not significant.</P>
<P>Carotid restenosis could be considered as a 'soft' outcome susceptible to poor reliability. Measurement of carotid restenosis was based on ultrasonography evaluations and criteria which differed in all the studies examined. Interobserver variability and potential inaccuracy may have biased the assessment of these outcomes. In this regard, differences in defining other outcomes in various studies should also be considered: i.e. not all trials used the same definition for stroke or the same criteria in evaluation of cranial nerve injuries. We accepted all outcome measures as defined by the trial author. Since we considered restenosis as a relevant measure of failure in CEA treatment, all restenoses as defined by the trial author were considered valid.</P>
<P>Furthermore, due to the different morphology of the operated arteries on duplex scan in each treatment group (eversion, synthetic patch, primary closure), complete blinding was impossible in detecting carotid restenosis. Due to these unavoidable flaws, the results of this review should be applied with caution.</P>
<P>It remains unclear whether restenosis or carotid occlusion increased the risk of clinical neurological events. Restenosis detected by routine duplex scanning may not be clinically important. In one study of our review (<LINK REF="STD-EVEREST-1998" TYPE="STUDY">EVEREST 1998</LINK>) there was no significant association between restenosis and risk of stroke, and only one patient with ipsilateral stroke subsequent to restenosis was found. However, no definite conclusions can be drawn on the impact of the eversion technique on the risk of restenosis-related stroke.</P>
<P>There is evidence that carotid patching is associated with reduced risk of arterial occlusion and restenosis (<LINK REF="REF-Counsell-1999" TYPE="REFERENCE">Counsell 1999</LINK>), however, the costs of prosthetic material and procedural timing for patching have not been determined in the analysed trials. In four studies of our review, only CEA with patch (of different materials) was considered in comparison to the conventional CEA group: Dacron in Balzer study (<LINK REF="STD-Balzer-1998" TYPE="STUDY">Balzer 1998</LINK>), polytetrafluorethylene in Ballotta studies (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>) and saphenous vein in Vanmaele study (<LINK REF="STD-Vanmaele-1994" TYPE="STUDY">Vanmaele 1994</LINK>). Data were insufficient to draw conclusions on whether carotid patching was associated with fewer outcome events in comparison to eversion CEA.</P>
<P>It should be noted that some flaws were present in the studies included in this review. Some of these trials were too small to achieve an adequate statistical power. Moreover, in the smallest trials (<LINK REF="STD-Ballotta-1999" TYPE="STUDY">Ballotta 1999</LINK>; <LINK REF="STD-Ballotta-2000" TYPE="STUDY">Ballotta 2000</LINK>), the sample size had not been calculated.</P>
<P>Finally, considering that three trials included patients undergoing bilateral endarterectomy, analysis of clinical outcome events for these patients may be inaccurate. In trials that had been randomised at the level of the artery, data analysis at the level of the patient was inevitably inaccurate because the same patient can be exposed twice to risk of death or stroke. In patients undergoing bilateral procedures, it is difficult to establish on which side stroke or perioperative complications were related. Fortunately, in most trials it was clear in the reports the exact number of randomised patients for each arm and whether strokes occurring after surgery were ipsilateral to the operated artery. Eversion CEA was not associated with increased risk of ipsilateral stroke.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>There is insufficient evidence from randomised trials to reliably determine the relative risks and benefits of eversion and conventional CEA. It is possible that carotid eversion is associated with a lower risk of long-term carotid occlusion and restenosis but it is still unclear whether this is associated with a lower rate of subsequent neurological events. Procedural costs were not studied in RCTs, thereby no clear indication can be given on this matter. Until better evidence is available, the choice of the surgical technique for CEA should depend on the experience and preference of the operating surgeon.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Further randomised trials are needed to more precisely define the relative and absolute benefits and risks of eversion and conventional carotid endarterectomy, and establish the importance (or not) of restenosis of the carotid artery (that was previously operated on) as a cause of subsequent as far as we know, since our initial review two years ago. Studies analysing the costs of eversion and conventional carotid endarterectomy are also needed. </P>
<P>Further investigation is required to define the clinical significance of restenosis.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-08-20 12:13:29 +0100" MODIFIED_BY="Hazel Fraser">
<P>We are grateful to the authors who responded to our queries and provided additional information, particularly Dr E Ballotta, Dr K Balzer, and Prof R Vanmaele. We also thank Brenda Thomas for providing newly identified RCTs and Hazel Fraser for helping with our review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-08-20 11:29:52 +0100" MODIFIED_BY="Hazel Fraser">
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-20 11:29:50 +0100" MODIFIED_BY="Hazel Fraser">
<P>Piergiorgio Cao: conception and design of study, analysis and interpretation of data, final approval of the version to be published.<BR/>Paola De Rango: conception and design of study, analysis and interpretation of data.<BR/>Simona Zannetti: drafting the review, writing the review.<BR/>Giuseppe Giordano: entering data into RevMan.<BR/>Stefano Ricci: data management for the review.<BR/>Maria Grazia Celani: data management for the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-08-20 11:47:18 +0100" MODIFIED_BY="Hazel Fraser">
<STUDIES MODIFIED="2008-08-20 11:47:18 +0100" MODIFIED_BY="Hazel Fraser">
<INCLUDED_STUDIES MODIFIED="2008-08-20 11:47:18 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY DATA_SOURCE="PUB" ID="STD-Ballotta-1999" MODIFIED="2008-08-20 11:47:18 +0100" MODIFIED_BY="Hazel Fraser" NAME="Ballotta 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-08-20 11:47:18 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ballotta E, Da Giau G, Saladini M, Abbruzzese E, Renon L. Toniato A</AU>
<TI>Carotid endarterectomy with patch closure versus carotid eversion endarterectomy and reimplantation: a prospective randomized study</TI>
<SO>Surgery</SO>
<YR>1999</YR>
<VL>125</VL>
<PG>271-9</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:56:13 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ballotta-2000" MODIFIED="2008-08-19 15:56:19 +0100" MODIFIED_BY="Hazel Fraser" NAME="Ballotta 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-08-19 15:56:19 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ballotta E, Renon L, Da Giau G, Toniato A, Baracchini C, Abbruzzese E</AU>
<TI>A prospective randomized study on bilateral carotid endarterectomy: patching versus eversion. Clinical outcome and restenosis</TI>
<SO>Ann Surg</SO>
<YR>2000</YR>
<VL>232</VL>
<PG>119-25</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:56:19 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Balzer-1998" MODIFIED="2008-08-19 15:56:29 +0100" MODIFIED_BY="Hazel Fraser" NAME="Balzer 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-08-19 15:56:29 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Balzer K</AU>
<TI>Eversion versus conventional carotid endarterectomy</TI>
<SO>Perioperative monitoring in carotid surgery</SO>
<YR>1998</YR>
<PG>159-165</PG>
<ED>Horsch S, Ktenidis K.</ED>
<PB>Darmstadt Steinkopff Springer</PB>
<IDENTIFIERS MODIFIED="2008-08-19 15:56:29 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-EVEREST-1998" MODIFIED="2008-08-19 15:56:38 +0100" MODIFIED_BY="Hazel Fraser" NAME="EVEREST 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-08-19 15:56:38 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cao P, Giordano G, De Rango P, Zannetti S, Chiesa R, Coppi G, Palombo D, Spartera C, Stancanelli V, Vecchiati E, and collaborators of the EVEREST Study Group</AU>
<TI>A randomized study on eversion versus standard carotid endarterectomy: study design and preliminary results: the EVEREST trial</TI>
<SO>J Vasc Surg</SO>
<YR>1998</YR>
<VL>27</VL>
<PG>595-605</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:56:38 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vanmaele-1994" MODIFIED="2008-08-19 15:57:13 +0100" MODIFIED_BY="Hazel Fraser" NAME="Vanmaele 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-08-19 15:56:49 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Vanmaele RG, Van Schil PE, DeMaeseneer MG, Lehert P, Van Look RF</AU>
<TI>Endarterectomy and reimplantation for carotid stenosis</TI>
<SO>Modern Vascular Surgery</SO>
<YR>1994</YR>
<PG>85-96</PG>
<ED>Chang JB</ED>
<PB>Springer-Verlag</PB>
<CY>New York</CY>
<IDENTIFIERS MODIFIED="2008-08-19 15:56:49 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE MODIFIED="2008-08-19 15:57:00 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vanmaele RG, Van Schil PE, DeMaeseneer MG, Meese G, Lehert PH, Van Look RF</AU>
<TI>Division-endarterectomy-anastomosis of the internal carotid artery: a prospective randomized comparative study</TI>
<SO>Cardiovasc Surg</SO>
<YR>1994</YR>
<VL>2</VL>
<NO>5</NO>
<PG>573-581</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:57:00 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE MODIFIED="2008-08-19 15:57:13 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="BOOK">
<AU>Vanmaele RG</AU>
<SO>The technique of division-endarterectomy-anastomosis for the surgical treatment of extracranial carotid artery atheromatosis</SO>
<YR>1992</YR>
<PB>Antwerp University UIA</PB>
<CY>Antwerp</CY>
<IDENTIFIERS MODIFIED="2008-08-19 15:57:13 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Darling-1995" NAME="Darling 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darling RC, Paty PSK, Shah DM, Chang BB, Leather RP</AU>
<TI>Carotid eversion endarterectomy. Preliminary results of a prospective randomized trial</TI>
<SO>Stroke</SO>
<YR>1995</YR>
<VL>26</VL>
<PG>186 (Abst 159)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-08-19 15:58:39 +0100" MODIFIED_BY="Hazel Fraser">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-19 15:58:39 +0100" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-ACAS-1995" NAME="ACAS 1995" TYPE="JOURNAL_ARTICLE">
<AU>Executive Committee for the Asymptomatic Carotid Atherosclerosis Study</AU>
<TI>Endarterectomy for asymptomatic carotid artery stenosis</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>1421-1428</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berguer-1993" MODIFIED="2008-08-19 15:43:13 +0100" MODIFIED_BY="Hazel Fraser" NAME="Berguer 1993" TYPE="BOOK_SECTION">
<AU>Berguer R</AU>
<TI>Eversion endarterectomy of the carotid bifurcation</TI>
<SO>Current critical problems in vascular surgery</SO>
<YR>1993</YR>
<VL>5</VL>
<PG>441-447</PG>
<ED>Veith FJ</ED>
<PB>Quality Medical Publishing</PB>
<CY>St. Louis</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cao-1997" MODIFIED="2008-08-19 15:43:15 +0100" MODIFIED_BY="Hazel Fraser" NAME="Cao 1997" TYPE="JOURNAL_ARTICLE">
<AU>Cao P, Giordano G, De Rango P, Caporali S, Lenti M, Ricci S, Moggi L</AU>
<TI>Eversion versus conventional carotid endarterectomy: A prospective study</TI>
<SO>Eur J Vasc Endovasc Surg</SO>
<YR>1997</YR>
<VL>14</VL>
<PG>96-104</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chang-2000" MODIFIED="2008-08-19 15:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Chang 2000" TYPE="JOURNAL_ARTICLE">
<AU>Chang B, Darling III RC, Patel M, Roddy SP, Paty PS, Kreienberg PB, Lloyd WE, Shah DM</AU>
<TI>Use of shunt with eversion carotid endarterectomy</TI>
<SO>J Vasc Surg</SO>
<YR>2000</YR>
<VL>32</VL>
<NO>4</NO>
<PG>655-62</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:57:24 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-Counsell-1999" MODIFIED="2008-08-19 15:42:29 +0100" MODIFIED_BY="Hazel Fraser" NAME="Counsell 1999" TYPE="COCHRANE_REVIEW">
<AU>Counsell C, Warlow C, Naylor R</AU>
<TI>Patches of different types for carotid patch angioplasty</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1999</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-08-19 15:42:12 +0100" MODIFIED_BY="Hazel Fraser">
<IDENTIFIER MODIFIED="2008-08-19 15:42:12 +0100" MODIFIED_BY="Hazel Fraser" TYPE="DOI" VALUE="Art. No.: CD000071. DOI: 10.1002/14651858.CD000071"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Darling-III-1996" MODIFIED="2008-08-19 15:43:19 +0100" MODIFIED_BY="Hazel Fraser" NAME="Darling III 1996" TYPE="JOURNAL_ARTICLE">
<AU>Darling III RC, Paty PSK, Shah DM, Chang BB, Leather RP</AU>
<TI>Eversion endarterectomy of the internal carotid artery: Technique and results in 449 procedures</TI>
<SO>Surgery</SO>
<YR>1996</YR>
<VL>120</VL>
<PG>635-640</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DeBakey-1959" NAME="DeBakey 1959" TYPE="JOURNAL_ARTICLE">
<AU>DeBakey ME, Crawford ES, Cooley DA, et al</AU>
<TI>Surgical consideration of occlusive disease in the innominate, carotid, subclavian and vertebral arteries</TI>
<SO>Ann Surg</SO>
<YR>1959</YR>
<VL>149</VL>
<PG>690-710</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Economopoulos-1999" MODIFIED="2008-08-19 15:57:37 +0100" MODIFIED_BY="Hazel Fraser" NAME="Economopoulos 1999" TYPE="JOURNAL_ARTICLE">
<AU>Economopoulos KJ, Gentile AT, Berman SS</AU>
<TI>Comparison of carotid endarterectomy using primary closure, patch closure, and eversion technique</TI>
<SO>Am J Surg</SO>
<YR>1999</YR>
<VL>178</VL>
<PG>505-10</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:57:37 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-ECST-1991" MODIFIED="2008-08-19 15:43:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="ECST 1991" TYPE="JOURNAL_ARTICLE">
<AU>European Carotid Surgery Trialists' Collaborative Group (ECST)</AU>
<TI>MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>337</VL>
<PG>1235-1243</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ECST-1998" NAME="ECST 1998" TYPE="JOURNAL_ARTICLE">
<AU>European Carotid Surgery Trialists' Collaborative Group (ECST)</AU>
<TI>Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<PG>1379-1387</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Entz-1996" MODIFIED="2008-08-19 15:43:28 +0100" MODIFIED_BY="Hazel Fraser" NAME="Entz 1996" TYPE="JOURNAL_ARTICLE">
<AU>Entz L, Jaranyi Z, Nemes A</AU>
<TI>Eversion endarterectomy in surgery of internal carotid artery</TI>
<SO>Cardiovasc Surg</SO>
<YR>1996</YR>
<VL>2</VL>
<PG>190-194</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Etheredge-1970" MODIFIED="2008-08-19 15:43:31 +0100" MODIFIED_BY="Hazel Fraser" NAME="Etheredge 1970" TYPE="JOURNAL_ARTICLE">
<AU>Etheredge SN</AU>
<TI>A simple technique for carotid endarterectomy</TI>
<SO>Am J Surg</SO>
<YR>1970</YR>
<VL>120</VL>
<PG>275-278</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Frericks-1998" NAME="Frericks 1998" TYPE="JOURNAL_ARTICLE">
<AU>Frericks H, Kievit J, van Baalen JM, van Bockel JH</AU>
<TI>Carotid recurrent stenosis and risk of ipsilateral stroke. A systematic review of the literature</TI>
<SO>Stroke</SO>
<YR>1998</YR>
<VL>29</VL>
<PG>244-250</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Green-2000" MODIFIED="2008-08-19 15:57:50 +0100" MODIFIED_BY="Hazel Fraser" NAME="Green 2000" TYPE="JOURNAL_ARTICLE">
<AU>Green R, Greenberg R, Illig K, Shortell C, Ouriel K</AU>
<TI>Eversion endarterectomy of the carotid artery: technical considerations and recurrent stenoses</TI>
<SO>J Vasc Surg</SO>
<YR>2000</YR>
<VL>32</VL>
<NO>6</NO>
<PG>1052-61</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:57:50 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-Katras-2001" MODIFIED="2008-08-19 15:57:56 +0100" MODIFIED_BY="Hazel Fraser" NAME="Katras 2001" TYPE="JOURNAL_ARTICLE">
<AU>Katras T, Baltazar U, Rush D, Sutterfield C, Harvill L, Stanton Jr P</AU>
<TI>Durability of eversion carotid endarterectomy: comparison with primary closure and carotid patch angioplasty</TI>
<SO>J Vasc Surg</SO>
<YR>2001</YR>
<VL>34</VL>
<PG>453-458</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:57:56 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-Kieny-1993" NAME="Kieny 1993" TYPE="JOURNAL_ARTICLE">
<AU>Kieny R, Hirsch D, Seiller C, Thiranos JC, Petit H</AU>
<TI>Does carotid eversion endarterectomy and reimplantation reduce the risk of restenosis?</TI>
<SO>Ann Vasc Surg</SO>
<YR>1993</YR>
<VL>7</VL>
<PG>407-413</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Koskas-1995" MODIFIED="2008-08-19 15:43:35 +0100" MODIFIED_BY="Hazel Fraser" NAME="Koskas 1995" TYPE="JOURNAL_ARTICLE">
<AU>Koskas K, Kieffer E, Bahnini A, Ruotolo C, Rancurel G</AU>
<TI>Carotid eversion endarterectomy and reimplantation : short and long-term results</TI>
<SO>Ann Vasc Surg</SO>
<YR>1995</YR>
<VL>9</VL>
<PG>9-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mehta-2001" MODIFIED="2008-08-19 15:58:14 +0100" MODIFIED_BY="Hazel Fraser" NAME="Mehta 2001" TYPE="JOURNAL_ARTICLE">
<AU>Mehta M, Rahmani O, Dietzek A, Mecenas J, Scher L, Friedman SG, Safa T, Ohki T, Veith F</AU>
<TI>Eversion technique increases the risk for post-carotid endarterectomy hypertension</TI>
<SO>J Vasc Surg</SO>
<YR>2001</YR>
<VL>34</VL>
<PG>839-845</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:58:14 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-Moore-1998" NAME="Moore 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moore WS, Kempczinski RF, Nelson JJ, Toole JF; for the ACAS Investigators</AU>
<TI>Recurrent carotid stenosis. Results of the Asymptomatic Carotid Atherosclerosis Study</TI>
<SO>Stroke</SO>
<YR>1998</YR>
<VL>29</VL>
<PG>2018-2025</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NASCET-1991" NAME="NASCET 1991" TYPE="JOURNAL_ARTICLE">
<AU>North American Symptomatic Carotid Endarterectomy Trial Collaborators (NASCET)</AU>
<TI>Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis</TI>
<SO>N Engl J Med</SO>
<YR>1991</YR>
<VL>315</VL>
<PG>445-453</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NASCET-1998" MODIFIED="2008-08-19 15:43:38 +0100" MODIFIED_BY="Hazel Fraser" NAME="NASCET 1998" TYPE="JOURNAL_ARTICLE">
<AU>Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, et al for the North American Symptomatic Carotid Endarterectomy Trial Collaborators (NASCET)</AU>
<TI>Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis</TI>
<SO>N Engl J Med</SO>
<YR>1998</YR>
<VL>339</VL>
<PG>1415-1425</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peiper-1999" MODIFIED="2008-08-19 15:58:25 +0100" MODIFIED_BY="Hazel Fraser" NAME="Peiper 1999" TYPE="JOURNAL_ARTICLE">
<AU>Peiper Ch, Nowack J, Ktenidis K, Reifenhauser W, Keresztury G, Horsch S</AU>
<TI>Eversion endarterectomy versus open thromboendarterectomy and patch plasty for the treatment of internal carotid artery stenosis</TI>
<SO>Eur J Vasc Endovasc Surg</SO>
<YR>1999</YR>
<VL>18</VL>
<PG>339-343</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:58:25 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-Radak-2000" MODIFIED="2008-08-19 15:58:34 +0100" MODIFIED_BY="Hazel Fraser" NAME="Radak 2000" TYPE="JOURNAL_ARTICLE">
<AU>Radak D, Radevic B, Sternic N, et al</AU>
<TI>Single center experience on eversion versus standard carotid endarterectomy: a prospective non-randomized study</TI>
<SO>Cardiovasc Surg</SO>
<YR>2000</YR>
<VL>8</VL>
<PG>422-28</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:58:34 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-Raftopoulos-2000" MODIFIED="2008-08-19 15:58:39 +0100" MODIFIED_BY="Hazel Fraser" NAME="Raftopoulos 2000" TYPE="JOURNAL_ARTICLE">
<AU>Raftopoulos I, Haid SP</AU>
<TI>Carotid endarterectomy with reimplantation of the internal carotid artery: perioperative risk, and incidence of recurrent stenosis in 167 procedures</TI>
<SO>Cardiovasc Surg</SO>
<YR>2000</YR>
<VL>8</VL>
<NO>7</NO>
<PG>519-525</PG>
<IDENTIFIERS MODIFIED="2008-08-19 15:58:39 +0100" MODIFIED_BY="Hazel Fraser"/>
</REFERENCE>
<REFERENCE ID="REF-Raithel-1993" MODIFIED="2008-08-19 15:43:42 +0100" MODIFIED_BY="Hazel Fraser" NAME="Raithel 1993" TYPE="BOOK_SECTION">
<AU>Raithel D, Kasprzak PM</AU>
<TI>The eversion endarterectomy. A new technique</TI>
<SO>Surgery for stroke</SO>
<YR>1993</YR>
<PG>183-193</PG>
<ED>Greenhalgh RM and Hollier LH</ED>
<PB>WB Sanders</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reigner-1995" NAME="Reigner 1995" TYPE="JOURNAL_ARTICLE">
<AU>Reigner B, Reveilleau P, Gayral M, Papon X, Enon B, Chevalier JM</AU>
<TI>Eversion endarterectomy of the internal carotid artery: mid-term results of a new technique</TI>
<SO>Ann Vasc Surg</SO>
<YR>1995</YR>
<VL>9</VL>
<PG>241-246</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shah-1998" MODIFIED="2008-08-19 15:43:45 +0100" MODIFIED_BY="Hazel Fraser" NAME="Shah 1998" TYPE="JOURNAL_ARTICLE">
<AU>Shah DM, Darling III RC, Chang BB, Paty PSK, Kreienberg PB, Lloyd WE, Leather RP</AU>
<TI>Carotid endarterectomy by eversion technique, its safety and durability</TI>
<SO>Ann Surg</SO>
<YR>1998</YR>
<VL>4</VL>
<PG>471-478</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vanmaele-1990" NAME="Vanmaele 1990" TYPE="JOURNAL_ARTICLE">
<AU>Vanmaele R, Van Schil P, DeMaeseneer MG, Lehert P, Van Look RF</AU>
<TI>Division- endarterectomy-anastomosis of the carotid bifurcation</TI>
<SO>J Cardiovasc Surg</SO>
<YR>1992</YR>
<VL>33</VL>
<PG>11S</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-08-20 11:55:28 +0100" MODIFIED_BY="Hazel Fraser">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-08-20 11:55:28 +0100" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-08-20 11:54:47 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Ballotta-1999">
<CHAR_METHODS MODIFIED="2008-08-20 11:54:43 +0100" MODIFIED_BY="Hazel Fraser">
<P>Monocentric, single surgeon<BR/>Randomisation: list of randomly generated binary digits<BR/>No sample size calculation<BR/>Patient assignment by sequentially numbered, sealed, opaque envelopes<BR/>Recruitment period: 5 years<BR/>Mean duration of follow up 34 months (range 1.69 months)<BR/>No patients were lost to follow up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 11:33:42 +0100" MODIFIED_BY="Hazel Fraser">
<P>310 patients (31% female)<BR/>Mean age 70 years (41 to 89 years)<BR/>336 CEA<BR/>26 bilateral CEA<BR/>Asymptomatic = 46%: 45% in eversion group and 48% in control group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 11:34:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two groups. <BR/>Control: PTFE patch CEA<BR/>Treatment: 169 arteries by eversion CEA and 167 arteries by CEAP (carotid endarterectomy with PTFE patch)<BR/>158 patients by eversion and 152 patients by patch</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 11:34:15 +0100" MODIFIED_BY="Hazel Fraser">
<P>Perioperative mortality<BR/>Perioperative stroke<BR/>Recurrent carotid stenosis/occlusion<BR/>Local complications: neck hematoma, cranial nerve injuries<BR/>Perioperative myocardial infarction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-20 11:54:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>Exclusions: repeated CEA; CEA with combined CABG, or patients with associated supraaortic trunk lesions requiring contemporary surgery<BR/>Patients randomised twice = 26 (bilateral procedures)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 11:54:56 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Ballotta-2000">
<CHAR_METHODS MODIFIED="2008-08-20 11:54:56 +0100" MODIFIED_BY="Hazel Fraser">
<P>Monocentric, single surgeon<BR/>Randomisation: list of randomly generated binary digits<BR/>No sample size calculation<BR/>Patient assignment by sequentially numbered, sealed, opaque envelopes<BR/>Only patients undergoing bilateral CEA were randomised to sequential surgical treatment (staged eversion/patch or patch/eversion)<BR/>Mean duration of follow up 40 months (range 6 to 69 months)<BR/>No patients were lost to follow up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 11:35:17 +0100" MODIFIED_BY="Hazel Fraser">
<P>68 patients (25% female) <BR/>Mean age 70 years (range 41 to 84 years)<BR/>68 CEA, all 68 bilateral<BR/>Asymptomatic = 36%: 35% in eversion group and 38% in control group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 11:35:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two groups<BR/>Control: PTFE patch CEA<BR/>Treatment: 68 eversion CEA followed by contralateral PTFE patch CEA and 68 PTFE patch CEA followed by contralateral eversion CEA</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 11:35:42 +0100" MODIFIED_BY="Hazel Fraser">
<P>Perioperative mortality<BR/>Perioperative stroke<BR/>Recurrent carotid stenosis/occlusion<BR/>Local complications: neck hematoma, cranial nerve injuries<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-20 11:35:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Some patients (18) were included in another study in the review. These patients and related outcome events were excluded from the analysis<BR/>Exclusions: repeated CEA; CEA with combined CABG, or patients with associated supraaortic trunk lesions requiring combined surgery<BR/>All patients underwent CEA twice with a different technique on each side (= 68)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 11:55:04 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Balzer-1998">
<CHAR_METHODS MODIFIED="2008-08-20 11:55:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>Monocentric, different surgeons<BR/>Randomisation: blocks of 50 changing the operative method on a monthly term<BR/>Sample size: 300 for each group<BR/>Recruitment period: 1 year<BR/>Mean follow up: 24 months <BR/>Lost to follow up: 22 (3.9%); 9 in Dacron patch group and 13 in eversion CEA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 11:55:04 +0100" MODIFIED_BY="Hazel Fraser">
<P>564 patients (34% female)<BR/>Mean age 66 years<BR/>No patients randomised twice<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 11:36:55 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two groups<BR/>Control: Dacron patch CEA<BR/>Treatment: 286 eversion CEA and 278 Dacron patch CEA</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 11:37:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>Perioperative (in hospital) death<BR/>Perioperative (in hospital) stroke<BR/>Recurrent carotid stenosis<BR/>Late stroke<BR/>Late death<BR/>Perioperative local complications: neck hematoma<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Exclusions: repeated CEA, bilateral CEA<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 11:55:15 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-EVEREST-1998">
<CHAR_METHODS MODIFIED="2008-08-20 11:55:07 +0100" MODIFIED_BY="Hazel Fraser">
<P>Multicentric: 7 centers<BR/>Randomisation: computer-generated list stratified for each site by the central co-ordinating center<BR/>Sample size: 600 in each group<BR/>Patient assignment by sequentially numbered, sealed envelopes<BR/>Recruitment period: October 1994 to March 1997<BR/>Cross-over = 22<BR/>Mean follow up: 33 months (12 to 55 months)<BR/>Lost to follow up: 11(0.8%): 4 in conventional CEA group and 7 in eversion CEA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 11:55:11 +0100" MODIFIED_BY="Hazel Fraser">
<P>1353 patients (27% female)<BR/>Mean age 69 years (38 to 92 years)<BR/>1353 CEA<BR/>No patients randomised twice<BR/>Asymptomatic = 56%: 55% in eversion group and 56% in control group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 11:38:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two groups<BR/>Control: conventional CEA (primary closure or patch)<BR/>Treatment: 678 eversion CEA and 675 conventional CEA (419 primary closure and 256 patch)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 11:38:52 +0100" MODIFIED_BY="Hazel Fraser">
<P>Perioperative death<BR/>Perioperative and late stroke<BR/>Early carotid occlusion<BR/>Carotid restenosis/occlusion<BR/>Perioperative local complications: neck hematoma, cranial nerve injuries<BR/>Perioperative myocardial infarction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-20 11:55:15 +0100" MODIFIED_BY="Hazel Fraser">
<P>Exclusions: repeated CEA, CEA with concomitant CABG or requiring contemporary surgery; bilateral CEA; emergencies<BR/>Bilateral CEA: all patients were randomised once</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-20 11:55:28 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Vanmaele-1994">
<CHAR_METHODS MODIFIED="2008-08-20 11:55:19 +0100" MODIFIED_BY="Hazel Fraser">
<P>Monocentric<BR/>Randomisation: non-stratified; following a list of at random generated binary digits<BR/>Cross-over = 2<BR/>Recruitment period: November 1988 to November 1991<BR/>Mean follow up = 338 days (375 + 276 days)<BR/>No patients were lost to follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-20 11:55:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>170 patients (23% female) <BR/>Mean age 65 years (43 to 85 years)<BR/>200 CEA<BR/>30 patients randomised twice (bilateral procedures)<BR/>Asymptomatic = 23%: 23% in eversion group and 23% in control group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-20 11:46:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two groups<BR/>Control: sapheneous vein patch CEA<BR/>Treatment: 102 eversion CEA and 98 saphenous vein patch CEA</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-20 11:46:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>Perioperative death <BR/>Perioperative and late stroke<BR/>Carotid restenosis/occlusion<BR/>Local complications: cranial nerve injuries, false aneurysm</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-20 11:55:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>Exclusions: reinterventions, fibromuscolar dysplasia, kinking, carotid body tumor, aneurysm, dissection<BR/>Two different techniques for eversion CEA<BR/>Patients randomised twice = 30 (bilateral procedures)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Darling-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This trial originally had a randomised design but randomisation was discontinued and the trial proceeded in a non-randomised fashion. The principal investigator has been contacted, but the data on the initial randomised patients are no longer available.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Ballotta-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Ballotta-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Balzer-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-EVEREST-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Vanmaele-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-08-20 11:57:08 +0100" MODIFIED_BY="Hazel Fraser">
<COMPARISON ID="CMP-001" MODIFIED="2008-08-20 11:57:08 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<NAME>Eversion vs conventional CEA</NAME>
<DICH_OUTCOME CHI2="6.2113025902420675" CI_END="1.8168993201781227" CI_START="0.10447169114227907" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.43567711050073044" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" I2="67.80063487581506" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.25933086241947306" LOG_CI_START="-0.9810013750673822" LOG_EFFECT_SIZE="-0.3608352563239545" METHOD="MH" NO="1" P_CHI2="0.04479536939717166" P_Q="0.0" P_Z="0.2541286662340979" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.0065879681603114" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.0" Z="1.140378497587385">
<NAME>perioperative stroke and/or death</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2848152653922003" CI_START="0.5604658880513462" EFFECT_SIZE="1.1316187594553706" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.3588510917301181" LOG_CI_START="-0.2514508149724759" LOG_EFFECT_SIZE="0.05370013837882111" ORDER="1" O_E="0.0" SE="0.35849436104026466" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="0.12851820689766763" WEIGHT="46.76433693815137"/>
<DICH_DATA CI_END="1.081028319585187" CI_START="0.003464558222748349" EFFECT_SIZE="0.061198738170347" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.03383707126920008" LOG_CI_START="-2.460352135844251" LOG_EFFECT_SIZE="-1.2132575322875254" ORDER="2" O_E="0.0" SE="1.4650990866941371" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="2.1465153338319944" WEIGHT="16.83499795184227"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1828308145400106" CI_START="0.08487241295006054" EFFECT_SIZE="0.3168433451118963" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.07292263003261329" LOG_CI_START="-1.0712334505157026" LOG_EFFECT_SIZE="-0.49915541024154475" ORDER="4" O_E="0.0" SE="0.6720829453780219" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="0.4516954854679972" WEIGHT="36.400665110006365"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.108793780255913" CI_END="2.3705304248651746" CI_START="0.3113531390409678" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8591112203748076" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="67.26031239646439" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.3748455336968499" LOG_CI_START="-0.5067467513933647" LOG_EFFECT_SIZE="-0.06595060884825736" METHOD="PETO" NO="2" P_CHI2="0.04715130677027912" P_Q="1.0" P_Z="0.7693356650743133" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.0" Z="0.29324398656198686">
<NAME>perioperative death</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="10.916339599418276" CI_START="0.6778987832773289" EFFECT_SIZE="2.7203259606686423" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.0380770377947899" LOG_CI_START="-0.1688351455807718" LOG_EFFECT_SIZE="0.43462094610700897" ORDER="1" O_E="1.9911308203991132" SE="0.7089461908264649" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="1.9896351885302852" WEIGHT="53.35611736647754"/>
<DICH_DATA CI_END="1.243831628420941" CI_START="0.013250540251608099" EFFECT_SIZE="0.12838006488008538" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.09476159595237413" LOG_CI_START="-1.8777664142925292" LOG_EFFECT_SIZE="-0.8915024091700774" ORDER="2" O_E="-1.5290322580645161" SE="1.1586727173889815" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="0.7448664922259377" WEIGHT="19.97511112121076"/>
<DICH_DATA CI_END="2.5378534734608977" CI_START="0.0498124378291256" EFFECT_SIZE="0.35555121764128644" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4044665438798851" LOG_CI_START="-1.302662203302162" LOG_EFFECT_SIZE="-0.44909782971113843" ORDER="3" O_E="-1.0283687943262412" SE="1.0027758765183197" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="0.9944712781726227" WEIGHT="26.668771512311704"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.231328356344221" CI_END="1.292449181503713" CI_START="0.3757461419497846" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6968735851043408" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="24" I2="67.90411473078984" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.1114134758461308" LOG_CI_START="-0.4251054699254091" LOG_EFFECT_SIZE="-0.15684599703963917" METHOD="PETO" NO="3" P_CHI2="0.04434907866053772" P_Q="1.0" P_Z="0.25181499294438925" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.0" Z="1.1459520963417047">
<NAME>perioperative stroke</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4340394542985435" CI_START="0.5449483076429672" EFFECT_SIZE="1.151705553236678" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.38632761360040274" LOG_CI_START="-0.26364469179701283" LOG_EFFECT_SIZE="0.061341460901694914" ORDER="1" O_E="0.9689578713968956" SE="0.3817969496052434" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="6.860173373092341" WEIGHT="68.13659404871484"/>
<DICH_DATA CI_END="0.7397912160775231" CI_START="0.021686735185707032" EFFECT_SIZE="0.12666355512058475" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.13089082959227746" LOG_CI_START="-1.6638058236222386" LOG_EFFECT_SIZE="-0.8973483266072582" ORDER="2" O_E="-2.5483870967741935" SE="0.9004418555447982" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="1.2333565696466398" WEIGHT="12.249940538375578"/>
<DICH_DATA CI_END="1.4236380921082472" CI_START="0.0874868744936854" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" ORDER="3" O_E="-2.0567375886524824" SE="0.7116156614479168" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.9747358237999224" WEIGHT="19.61346541290957"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.231328356344221" CI_END="1.292449181503713" CI_START="0.3757461419497846" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6968735851043408" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="24" I2="67.90411473078984" I2_Q="81.59795184391133" ID="CMP-001.04" LOG_CI_END="0.1114134758461308" LOG_CI_START="-0.4251054699254091" LOG_EFFECT_SIZE="-0.15684599703963917" METHOD="PETO" NO="4" P_CHI2="0.04434907866053772" P_Q="0.019746466953077912" P_Z="0.25181499294438925" Q="5.434177714990551" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="99.99999999999999" Z="1.1459520963417047">
<NAME>perioperative stroke large vs small trials</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.4340394542985435" CI_START="0.5449483076429672" DF="0.0" EFFECT_SIZE="1.151705553236678" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.38632761360040274" LOG_CI_START="-0.26364469179701283" LOG_EFFECT_SIZE="0.061341460901694914" NO="1" P_CHI2="1.0" P_Z="0.71142335298556" STUDIES="1" TAU2="0.0" TOTAL_1="678" TOTAL_2="675" WEIGHT="68.13659404871484" Z="0.3699451595953245">
<NAME>large trials</NAME>
<DICH_DATA CI_END="2.4340394542985435" CI_START="0.5449483076429672" EFFECT_SIZE="1.151705553236678" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.38632761360040274" LOG_CI_START="-0.26364469179701283" LOG_EFFECT_SIZE="0.061341460901694914" ORDER="1" O_E="0.9689578713968956" SE="0.3817969496052434" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="6.860173373092341" WEIGHT="68.13659404871484"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7971506413536702" CI_END="0.7109160526194538" CI_START="0.07967959460545261" DF="1.0" EFFECT_SIZE="0.2380031572715511" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-0.1481816792091818" LOG_CI_START="-1.0986528841860494" LOG_EFFECT_SIZE="-0.6234172816976157" NO="2" P_CHI2="0.37194669925032897" P_Z="0.010137779780315792" STUDIES="3" TAU2="0.0" TOTAL_1="512" TOTAL_2="498" WEIGHT="31.863405951285145" Z="2.571094028034076">
<NAME>small trials</NAME>
<DICH_DATA CI_END="1.4236380921082472" CI_START="0.0874868744936854" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" ORDER="1" O_E="-2.0567375886524824" SE="0.7116156614479168" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.9747358237999224" WEIGHT="19.61346541290957"/>
<DICH_DATA CI_END="0.7397912160775231" CI_START="0.021686735185707032" EFFECT_SIZE="0.12666355512058475" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.13089082959227746" LOG_CI_START="-1.6638058236222386" LOG_EFFECT_SIZE="-0.8973483266072582" ORDER="2" O_E="-2.5483870967741935" SE="0.9004418555447982" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="1.2333565696466398" WEIGHT="12.249940538375578"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.231328356344221" CI_END="1.292449181503713" CI_START="0.3757461419497846" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6968735851043408" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="24" I2="67.90411473078984" I2_Q="75.52771440400029" ID="CMP-001.05" LOG_CI_END="0.1114134758461308" LOG_CI_START="-0.4251054699254091" LOG_EFFECT_SIZE="-0.15684599703963917" METHOD="PETO" NO="5" P_CHI2="0.04434907866053772" P_Q="0.043233433942668764" P_Z="0.25181499294438925" Q="4.086255025413163" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.00000000000001" Z="1.1459520963417047">
<NAME>perioperative stroke; sample size calculated : yes vs no</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.145073330931059" CI_END="1.709625278772127" CI_START="0.4572522694723594" DF="1.0" EFFECT_SIZE="0.8841549856591152" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="19" I2="53.38154712100426" ID="CMP-001.05.01" LOG_CI_END="0.23290093074590498" LOG_CI_START="-0.33984413031983074" LOG_EFFECT_SIZE="-0.0534715997869629" NO="1" P_CHI2="0.14302826826292658" P_Z="0.7143909675203508" STUDIES="2" TAU2="0.0" TOTAL_1="964" TOTAL_2="953" WEIGHT="87.75005946162443" Z="0.3659653025490111">
<NAME>sample size yes</NAME>
<DICH_DATA CI_END="2.4340394542985435" CI_START="0.5449483076429672" EFFECT_SIZE="1.151705553236678" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.38632761360040274" LOG_CI_START="-0.26364469179701283" LOG_EFFECT_SIZE="0.061341460901694914" ORDER="1" O_E="0.9689578713968956" SE="0.3817969496052434" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="6.860173373092341" WEIGHT="68.13659404871485"/>
<DICH_DATA CI_END="1.4236380921082472" CI_START="0.0874868744936854" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" ORDER="2" O_E="-2.0567375886524824" SE="0.7116156614479168" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.9747358237999224" WEIGHT="19.613465412909573"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7397912160775231" CI_START="0.021686735185707032" DF="0.0" EFFECT_SIZE="0.12666355512058475" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="-0.13089082959227746" LOG_CI_START="-1.6638058236222386" LOG_EFFECT_SIZE="-0.8973483266072582" NO="2" P_CHI2="1.0" P_Z="0.021751790615406042" STUDIES="2" TAU2="0.0" TOTAL_1="226" TOTAL_2="220" WEIGHT="12.24994053837558" Z="2.2946744060657758">
<NAME>sample size no</NAME>
<DICH_DATA CI_END="0.7397912160775231" CI_START="0.021686735185707032" EFFECT_SIZE="0.12666355512058475" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.13089082959227746" LOG_CI_START="-1.6638058236222386" LOG_EFFECT_SIZE="-0.8973483266072582" ORDER="1" O_E="-2.5483870967741935" SE="0.9004418555447982" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="1.2333565696466398" WEIGHT="12.24994053837558"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.231328356344221" CI_END="1.292449181503713" CI_START="0.3757461419497846" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6968735851043408" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="24" I2="67.90411473078984" I2_Q="12.06158100099159" ID="CMP-001.06" LOG_CI_END="0.1114134758461308" LOG_CI_START="-0.4251054699254091" LOG_EFFECT_SIZE="-0.15684599703963917" METHOD="PETO" NO="6" P_CHI2="0.04434907866053772" P_Q="0.28625340276214617" P_Z="0.25181499294438925" Q="1.1371594024351017" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.0" Z="1.1459520963417047">
<NAME>perioperative stroke blinding vs no blinding</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.0941689539091195" CI_END="1.6385131473138135" CI_START="0.41309260158462224" DF="1.0" EFFECT_SIZE="0.8227135946090052" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" I2="80.36971272355173" ID="CMP-001.06.01" LOG_CI_END="0.21444993048063657" LOG_CI_START="-0.3839525830910638" LOG_EFFECT_SIZE="-0.08475132630521362" NO="1" P_CHI2="0.024006449367842908" P_Z="0.5787738507212142" STUDIES="3" TAU2="0.0" TOTAL_1="904" TOTAL_2="895" WEIGHT="80.38653458709042" Z="0.5551766359026752">
<NAME>blinding</NAME>
<DICH_DATA CI_END="2.4340394542985435" CI_START="0.5449483076429672" EFFECT_SIZE="1.151705553236678" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.38632761360040274" LOG_CI_START="-0.26364469179701283" LOG_EFFECT_SIZE="0.061341460901694914" ORDER="1" O_E="0.9689578713968956" SE="0.3817969496052434" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="6.860173373092341" WEIGHT="68.13659404871484"/>
<DICH_DATA CI_END="0.7397912160775231" CI_START="0.021686735185707032" EFFECT_SIZE="0.12666355512058475" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.13089082959227746" LOG_CI_START="-1.6638058236222386" LOG_EFFECT_SIZE="-0.8973483266072582" ORDER="2" O_E="-2.5483870967741935" SE="0.9004418555447982" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="1.2333565696466398" WEIGHT="12.249940538375578"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4236380921082472" CI_START="0.0874868744936854" DF="0.0" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" NO="2" P_CHI2="1.0" P_Z="0.14330144644359044" STUDIES="1" TAU2="0.0" TOTAL_1="286" TOTAL_2="278" WEIGHT="19.61346541290957" Z="1.4636066795737295">
<NAME>poor blinding</NAME>
<DICH_DATA CI_END="1.4236380921082472" CI_START="0.0874868744936854" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" ORDER="1" O_E="-2.0567375886524824" SE="0.7116156614479168" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.9747358237999224" WEIGHT="19.61346541290957"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.184371138291233" CI_END="1.2285820036947337" CI_START="0.25405373995166236" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5586822467878805" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="16" I2="37.19325062488725" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.08940414947181263" LOG_CI_START="-0.5950744074121614" LOG_EFFECT_SIZE="-0.2528351289701744" METHOD="PETO" NO="7" P_CHI2="0.20348053321421788" P_Q="1.0" P_Z="0.1476290866727079" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.0" Z="1.4479569646827721">
<NAME>perioperative disabling stroke</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.852634944629901" CI_START="0.3474277875098505" EFFECT_SIZE="0.9955323437166927" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4552461979883864" LOG_CI_START="-0.459135449332849" LOG_EFFECT_SIZE="-0.0019446256722313194" ORDER="1" O_E="-0.015521064301552201" SE="0.5371123058986466" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="3.4663291119134505" WEIGHT="56.03568601257793"/>
<DICH_DATA CI_END="1.243831628420941" CI_START="0.013250540251608099" EFFECT_SIZE="0.12838006488008538" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.09476159595237413" LOG_CI_START="-1.8777664142925292" LOG_EFFECT_SIZE="-0.8915024091700774" ORDER="2" O_E="-1.5290322580645161" SE="1.1586727173889815" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="0.7448664922259377" WEIGHT="12.041298887693483"/>
<DICH_DATA CI_END="1.4236380921082472" CI_START="0.0874868744936854" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" ORDER="3" O_E="-2.0567375886524824" SE="0.7116156614479168" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.9747358237999224" WEIGHT="31.92301509972859"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.242895707549665" CI_END="1.9270465226631315" CI_START="0.44370833016220834" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9246872956387733" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" I2="69.16336231005094" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.28489219949820904" LOG_CI_START="-0.35290241777990544" LOG_EFFECT_SIZE="-0.03400510914084823" METHOD="PETO" NO="8" P_CHI2="0.07173380440401411" P_Q="1.0" P_Z="0.8344500705561981" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="904" TOTAL_2="895" WEIGHT="100.0" Z="0.20899765347926622">
<NAME>perioperative ipsilateral stroke</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.529945912946647" CI_START="0.5359343403760866" EFFECT_SIZE="1.1644247051837389" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.4031112366066867" LOG_CI_START="-0.2708884143353332" LOG_EFFECT_SIZE="0.06611141113567669" ORDER="1" O_E="0.9711751662971171" SE="0.39591073131542265" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="6.37977632664237" WEIGHT="89.54520933662393"/>
<DICH_DATA CI_END="1.243831628420941" CI_START="0.013250540251608099" EFFECT_SIZE="0.12838006488008538" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.09476159595237413" LOG_CI_START="-1.8777664142925292" LOG_EFFECT_SIZE="-0.8915024091700774" ORDER="2" O_E="-1.5290322580645161" SE="1.1586727173889815" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="0.7448664922259377" WEIGHT="10.454790663376075"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.211302590242068" CI_END="1.8168993201781234" CI_START="0.10447169114227903" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4356771105007304" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" I2="67.80063487581506" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.2593308624194732" LOG_CI_START="-0.9810013750673823" LOG_EFFECT_SIZE="-0.3608352563239546" METHOD="MH" NO="9" P_CHI2="0.04479536939717155" P_Q="0.0" P_Z="0.25412866623409813" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.0065879681603116" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.0" Z="1.1403784975873847">
<NAME>perioperative stroke and/or death: sample size yes</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.808144558180669" CI_END="2.3150801971658765" CI_START="0.19935993537221613" DF="1.0" EFFECT_SIZE="0.6793631123990223" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="24" I2="64.38929765610513" ID="CMP-001.09.01" LOG_CI_END="0.3645660400983931" LOG_CI_START="-0.7003621158089183" LOG_EFFECT_SIZE="-0.16789803785526258" NO="1" P_CHI2="0.09378689184310363" P_Z="0.5365613441193172" STUDIES="2" TAU2="0.5245551152164453" TOTAL_1="964" TOTAL_2="953" WEIGHT="83.16500204815773" Z="0.6180212354154323">
<NAME>sample size: yes</NAME>
<DICH_DATA CI_END="2.2848152653922003" CI_START="0.5604658880513462" EFFECT_SIZE="1.1316187594553706" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.3588510917301181" LOG_CI_START="-0.2514508149724759" LOG_EFFECT_SIZE="0.05370013837882111" ORDER="1" O_E="0.0" SE="0.35849436104026466" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="0.12851820689766763" WEIGHT="46.76433693815137"/>
<DICH_DATA CI_END="1.1828308145400106" CI_START="0.08487241295006054" EFFECT_SIZE="0.3168433451118963" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.07292263003261329" LOG_CI_START="-1.0712334505157026" LOG_EFFECT_SIZE="-0.49915541024154475" ORDER="2" O_E="0.0" SE="0.6720829453780219" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="0.4516954854679972" WEIGHT="36.400665110006365"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0810283195851877" CI_START="0.003464558222748349" DF="0.0" EFFECT_SIZE="0.061198738170347045" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.03383707126920035" LOG_CI_START="-2.460352135844251" LOG_EFFECT_SIZE="-1.2132575322875252" NO="2" P_CHI2="1.0" P_Z="0.05654845702660803" STUDIES="2" TAU2="0.0" TOTAL_1="226" TOTAL_2="220" WEIGHT="16.83499795184227" Z="1.9067848264867646">
<NAME>sample size: no</NAME>
<DICH_DATA CI_END="1.081028319585187" CI_START="0.003464558222748349" EFFECT_SIZE="0.061198738170347" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.03383707126920008" LOG_CI_START="-2.460352135844251" LOG_EFFECT_SIZE="-1.2132575322875254" ORDER="1" O_E="0.0" SE="1.4650990866941371" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="2.1465153338319944" WEIGHT="16.83499795184227"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.211302590242068" CI_END="1.8168993201781234" CI_START="0.10447169114227903" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4356771105007304" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" I2="67.80063487581506" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.2593308624194732" LOG_CI_START="-0.9810013750673823" LOG_EFFECT_SIZE="-0.3608352563239546" METHOD="MH" MODIFIED="2008-08-20 11:56:22 +0100" MODIFIED_BY="Hazel Fraser" NO="10" P_CHI2="0.04479536939717155" P_Q="0.0" P_Z="0.25412866623409813" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.0065879681603116" TOTALS="YES" TOTAL_1="1190" TOTAL_2="1173" WEIGHT="100.0" Z="1.1403784975873847">
<NAME>perioperative stroke and/or death quality of randomisation</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.162538934068838" CI_END="6.8366212665398685" CI_START="0.0188618443856738" DF="1.0" EFFECT_SIZE="0.3590978786532485" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" I2="75.97620068330482" ID="CMP-001.10.01" LOG_CI_END="0.8348415216277365" LOG_CI_START="-1.7244158424917675" LOG_EFFECT_SIZE="-0.4447871604320155" NO="1" P_CHI2="0.041327536241880125" P_Z="0.4957035427133646" STUDIES="3" TAU2="3.5974410744350225" TOTAL_1="904" TOTAL_2="895" WEIGHT="63.599334889993635" Z="0.6812654541545221">
<NAME>class A studies (adequate concealment)</NAME>
<DICH_DATA CI_END="2.2848152653922003" CI_START="0.5604658880513462" EFFECT_SIZE="1.1316187594553706" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.3588510917301181" LOG_CI_START="-0.2514508149724759" LOG_EFFECT_SIZE="0.05370013837882111" ORDER="1" O_E="0.0" SE="0.35849436104026466" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="0.12851820689766763" WEIGHT="46.76433693815137"/>
<DICH_DATA CI_END="1.081028319585187" CI_START="0.003464558222748349" EFFECT_SIZE="0.061198738170347" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.03383707126920008" LOG_CI_START="-2.460352135844251" LOG_EFFECT_SIZE="-1.2132575322875254" ORDER="2" O_E="0.0" SE="1.4650990866941371" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="2.1465153338319944" WEIGHT="16.83499795184227"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1828308145400106" CI_START="0.08487241295006054" DF="0.0" EFFECT_SIZE="0.3168433451118964" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="0.07292263003261329" LOG_CI_START="-1.0712334505157026" LOG_EFFECT_SIZE="-0.49915541024154464" NO="2" P_CHI2="1.0" P_Z="0.08724222164241849" STUDIES="1" TAU2="0.0" TOTAL_1="286" TOTAL_2="278" WEIGHT="36.400665110006365" Z="1.7101279159271663">
<NAME>class B studies (unadequate concealment)</NAME>
<DICH_DATA CI_END="1.1828308145400106" CI_START="0.08487241295006054" EFFECT_SIZE="0.3168433451118963" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.07292263003261329" LOG_CI_START="-1.0712334505157026" LOG_EFFECT_SIZE="-0.49915541024154475" ORDER="1" O_E="0.0" SE="0.6720829453780219" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="0.4516954854679972" WEIGHT="36.400665110006365"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.8025810161033897" CI_END="1.5807340607307299" CI_START="0.24479153162301728" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6220533030335479" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" I2="28.637210182036778" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.19885881131613362" LOG_CI_START="-0.611203610354125" LOG_EFFECT_SIZE="-0.20617239951899569" METHOD="PETO" NO="11" P_CHI2="0.24627921922470064" P_Q="1.0" P_Z="0.31843583808831655" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1017" TOTAL_2="1008" WEIGHT="100.0" Z="0.9976773810350199">
<NAME>early carotid occlusion</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.855788351239983" CI_START="0.30048400039696765" EFFECT_SIZE="1.3264881112390543" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7675853714059238" LOG_CI_START="-0.5221786475357763" LOG_EFFECT_SIZE="0.12270336193507378" ORDER="1" O_E="0.4922394678492239" SE="0.7576137691612153" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="1.7422251622985454" WEIGHT="39.44722504786128"/>
<DICH_DATA CI_END="1.2788200679967032" CI_START="0.01364942603192378" EFFECT_SIZE="0.1321179773015797" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10680944285758509" LOG_CI_START="-1.8648856106312275" LOG_EFFECT_SIZE="-0.8790380838868213" ORDER="2" O_E="-1.5089285714285714" SE="1.1581834344672515" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="167" VAR="0.7454959735759976" WEIGHT="16.879418388796953"/>
<DICH_DATA CI_END="2.3427192778872876" CI_START="0.13929862508590535" EFFECT_SIZE="0.5712596383186407" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3697202513077379" LOG_CI_START="-0.8560531701557296" LOG_EFFECT_SIZE="-0.24316645942399587" ORDER="3" O_E="-1.08" SE="0.7200253754439353" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="102" TOTAL_2="98" VAR="1.9288763819095478" WEIGHT="43.67335656334177"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.645314149902228" CI_END="1.109527253211083" CI_START="0.5245150568848567" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.762865486395413" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="65" I2="54.85540739945096" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.045137974232582326" LOG_CI_START="-0.2802420403052184" LOG_EFFECT_SIZE="-0.11755203303631798" METHOD="PETO" NO="12" P_CHI2="0.08410454551424817" P_Q="1.0" P_Z="0.15672385972683883" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1201" TOTAL_2="1188" WEIGHT="100.0" Z="1.4161764138336754">
<NAME>neck hematoma</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.634673654747506" CI_START="0.7602197662533761" EFFECT_SIZE="1.4152494444323507" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="17" LOG_CI_END="0.42072682876309353" LOG_CI_START="-0.11906084262140722" LOG_EFFECT_SIZE="0.1508329930708432" ORDER="1" O_E="3.4545454545454533" SE="0.3170739501633224" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="9.946696659983374" WEIGHT="36.335892007988086"/>
<DICH_DATA CI_END="1.0510687029398504" CI_START="0.21845052972727552" EFFECT_SIZE="0.47917274018559397" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" LOG_CI_END="0.02163110454631156" LOG_CI_START="-0.6606468978193533" LOG_EFFECT_SIZE="-0.31950789663652085" ORDER="2" O_E="-4.580357142857142" SE="0.4007734759201721" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="167" VAR="6.225898806350899" WEIGHT="22.743589596971418"/>
<DICH_DATA CI_END="1.1998143510699648" CI_START="0.3319222626020317" EFFECT_SIZE="0.631066632067907" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.0791140522615635" LOG_CI_START="-0.47896361773009577" LOG_EFFECT_SIZE="-0.19992478273426614" ORDER="3" O_E="-4.283687943262411" SE="0.3278175858821206" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="9.305409817186684" WEIGHT="33.99323190056272"/>
<DICH_DATA CI_END="1.445720373720841" CI_START="0.08391232914177058" EFFECT_SIZE="0.34830125444308524" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.16008430133088716" LOG_CI_START="-1.076174224095559" LOG_EFFECT_SIZE="-0.4580449613823359" ORDER="4" O_E="-2.0" SE="0.7261843774138906" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="1.8962962962962964" WEIGHT="6.927286494477774"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.868323594523041" CI_END="1.2339545479057052" CI_START="0.222392615539126" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5238533949161249" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="57" I2="61.87243745175617" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.09129916297332685" LOG_CI_START="-0.6528796374310454" LOG_EFFECT_SIZE="-0.2807902372288593" METHOD="MH" NO="13" P_CHI2="0.048812998091439574" P_Q="0.0" P_Z="0.13912700602010172" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.4353939831247961" TOTALS="YES" TOTAL_1="1017" TOTAL_2="1008" WEIGHT="100.0" Z="1.4790497979248503">
<NAME>cranial nerve injuries</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8144798880411714" CI_START="0.5924422759034679" EFFECT_SIZE="1.0368098159509203" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="25" LOG_CI_END="0.2587521587800878" LOG_CI_START="-0.22735395836065625" LOG_EFFECT_SIZE="0.015699100209715735" ORDER="1" O_E="0.0" SE="0.28554113947256066" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="0.08153374233128835" WEIGHT="36.965787775075476"/>
<DICH_DATA CI_END="1.7728945293424336" CI_START="0.29775773892316393" EFFECT_SIZE="0.7265625" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.2486828999060215" LOG_CI_START="-0.526136942093888" LOG_EFFECT_SIZE="-0.13872702109393326" ORDER="2" O_E="0.0" SE="0.4551330106108216" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="167" VAR="0.20714605734767025" WEIGHT="29.7392215125011"/>
<DICH_DATA CI_END="0.6187739880288814" CI_START="0.009910106889730805" EFFECT_SIZE="0.0783078307830783" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.2084679514254255" LOG_CI_START="-2.003921661219073" LOG_EFFECT_SIZE="-1.106194806322249" ORDER="3" O_E="0.0" SE="1.0546583967719898" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="102" TOTAL_2="98" VAR="1.112304333881664" WEIGHT="12.346489224865092"/>
<DICH_DATA CI_END="1.171020899861671" CI_START="0.07817540760479569" EFFECT_SIZE="0.30256410256410254" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.06856464623683564" LOG_CI_START="-1.1069298456775833" LOG_EFFECT_SIZE="-0.5191825997203738" ORDER="4" O_E="0.0" SE="0.6904912833421091" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.4767782123714327" WEIGHT="20.94850148755833"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.24762286072964668" CI_END="2.9169514099910785" CI_START="0.21246554693893469" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.787243086167196" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.4649291947890248" LOG_CI_START="-0.6727114843779478" LOG_EFFECT_SIZE="-0.10389114479446156" METHOD="PETO" NO="14" P_CHI2="0.6187539223219425" P_Q="1.0" P_Z="0.7203627586726081" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="836" TOTAL_2="827" WEIGHT="100.0" Z="0.3579740173476947">
<NAME>myocardial infarction</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.947211752180006" CI_START="0.20034261945626963" EFFECT_SIZE="0.9955588186725" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6943604995768694" LOG_CI_START="-0.698226652175411" LOG_EFFECT_SIZE="-0.0019330762992708327" ORDER="1" O_E="-0.006651884700665356" SE="0.8180125863568662" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="1.4944453153997923" WEIGHT="66.7368121898265"/>
<DICH_DATA CI_END="4.762244564433612" CI_START="0.05073219867317461" EFFECT_SIZE="0.4915273516022195" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6778116947766863" LOG_CI_START="-1.2947163154682169" LOG_EFFECT_SIZE="-0.30845231034576526" ORDER="2" O_E="-0.5290322580645161" SE="1.1586727173889815" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="0.7448664922259377" WEIGHT="33.2631878101735"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.033100976785887" CI_END="1.6379909941360542" CI_START="0.4287590728665579" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8380355004470551" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="19" I2="1.6281029404754916" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.2143115096296692" LOG_CI_START="-0.36778667685193456" LOG_EFFECT_SIZE="-0.07673758361113267" METHOD="PETO" NO="15" P_CHI2="0.3618410938146097" P_Q="1.0" P_Z="0.6053228188194839" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1115" TOTAL_2="1097" WEIGHT="100.0" Z="0.5167612737209734">
<NAME>stroke during follow-up (excluding perioperative)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6585005691982" CI_START="0.41670649399355075" EFFECT_SIZE="0.8313290308156513" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.21971562490560356" LOG_CI_START="-0.38016973140356064" LOG_EFFECT_SIZE="-0.08022705324897852" ORDER="1" O_E="-1.4877323420074333" SE="0.352375627776408" STUDY_ID="STD-EVEREST-1998" TOTAL_1="672" TOTAL_2="673" VAR="8.053566976686337" WEIGHT="94.15772816766393"/>
<DICH_DATA CI_END="6.431519433779347" CI_START="0.00252373285123211" EFFECT_SIZE="0.12740265648080762" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8083135862604542" LOG_CI_START="-2.5979566190698273" LOG_EFFECT_SIZE="-0.8948215164046867" ORDER="2" O_E="-0.5146579804560261" SE="2.0008599799204596" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="149" VAR="0.24978514360895077" WEIGHT="2.920345943646641"/>
<DICH_DATA CI_END="359.77016168908744" CI_START="0.14147378750062387" EFFECT_SIZE="7.134286748082604" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.556025141357673" LOG_CI_START="-0.8493240194922624" LOG_EFFECT_SIZE="0.8533505609327054" ORDER="3" O_E="0.4910714285714286" SE="2.0003189538334607" STUDY_ID="STD-Balzer-1998" TOTAL_1="285" TOTAL_2="275" VAR="0.2499202806122449" WEIGHT="2.921925888689427"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.172092417024021" CI_END="6.445203349966508" CI_START="0.7265976475492565" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.164040108699987" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" I2="53.96144325340918" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.8092366241525962" LOG_CI_START="-0.13870601255372075" LOG_EFFECT_SIZE="0.33526530579943775" METHOD="PETO" NO="16" P_CHI2="0.14053497666483894" P_Q="1.0" P_Z="0.16562860258325804" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="830" TOTAL_2="822" WEIGHT="100.0" Z="1.3863875285024974">
<NAME>ipsilateral stroke during follow-up (excl. perioperative)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.550564418979913" CI_START="0.881179847975659" EFFECT_SIZE="2.7449198630966984" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="0.9319947832612738" LOG_CI_START="-0.05493544344710418" LOG_EFFECT_SIZE="0.43852966990708475" ORDER="1" O_E="3.0044609665427506" SE="0.5797277005519138" STUDY_ID="STD-EVEREST-1998" TOTAL_1="672" TOTAL_2="673" VAR="2.9754447837923745" WEIGHT="92.25527639171416"/>
<DICH_DATA CI_END="6.431519433779347" CI_START="0.00252373285123211" EFFECT_SIZE="0.12740265648080762" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8083135862604542" LOG_CI_START="-2.5979566190698273" LOG_EFFECT_SIZE="-0.8948215164046867" ORDER="2" O_E="-0.5146579804560261" SE="2.0008599799204596" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="149" VAR="0.24978514360895077" WEIGHT="7.744723608285842"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.126423045981749" CI_END="0.7179078709193851" CI_START="0.3199056956213794" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4792314856502328" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="66" I2="56.171218670811555" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="-0.143931285170706" LOG_CI_START="-0.4949780276404441" LOG_EFFECT_SIZE="-0.3194546564055751" METHOD="PETO" NO="17" P_CHI2="0.05801611120693895" P_Q="1.0" P_Z="3.608737245954371E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1290" TOTAL_2="1267" WEIGHT="100.0" Z="3.5671581330940247">
<NAME>restenosis/occlusion best</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8760638050827154" CI_START="0.30056335242181986" EFFECT_SIZE="0.5131400142174422" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" LOG_CI_END="-0.05746426234079143" LOG_CI_START="-0.5220639738863216" LOG_EFFECT_SIZE="-0.28976411811355646" ORDER="1" O_E="-8.958333333333332" SE="0.27290817036750736" STUDY_ID="STD-EVEREST-1998" TOTAL_1="671" TOTAL_2="673" VAR="13.426627006287745" WEIGHT="57.091574856812905"/>
<DICH_DATA CI_END="0.5000990628452455" CI_START="0.03033216010583733" EFFECT_SIZE="0.12316283872581531" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.300943959292604" LOG_CI_START="-1.5180966602913646" LOG_EFFECT_SIZE="-0.9095203097919843" ORDER="2" O_E="-4.096969696969697" SE="0.7149615215697118" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="161" VAR="1.9562964265478773" WEIGHT="8.318399239516355"/>
<DICH_DATA CI_END="2.5421624167249295" CI_START="0.44507578371173445" EFFECT_SIZE="1.0636987026157194" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.4052032938317153" LOG_CI_START="-0.3515660347592037" LOG_EFFECT_SIZE="0.026818629536255783" ORDER="3" O_E="0.3125" SE="0.44453004968289817" STUDY_ID="STD-Balzer-1998" TOTAL_1="285" TOTAL_2="275" VAR="5.060550368962432" WEIGHT="21.518046942913575"/>
<DICH_DATA CI_END="4.60153072123469" CI_START="0.04842791290881962" EFFECT_SIZE="0.47206199700379553" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6629023258558219" LOG_CI_START="-1.314904247280414" LOG_EFFECT_SIZE="-0.32600096071229606" ORDER="4" O_E="-0.5561497326203209" SE="1.161773371360658" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="97" TOTAL_2="90" VAR="0.7408958533779688" WEIGHT="3.1503750759160756"/>
<DICH_DATA CI_END="0.6497366855305041" CI_START="0.04991751522897936" EFFECT_SIZE="0.18009231214795235" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.18726261134196" LOG_CI_START="-1.3017470408977605" LOG_EFFECT_SIZE="-0.7445048261198604" ORDER="5" O_E="-4.0" SE="0.6546536707079772" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="2.333333333333333" WEIGHT="9.921603884841089"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="22.344162800135635" CI_END="1.1341761757384479" CI_START="0.5409501069809728" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7832832971543462" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="66" I2="82.09823283253324" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.054680520349029864" LOG_CI_START="-0.2668427889822921" LOG_EFFECT_SIZE="-0.10608113431663116" METHOD="PETO" NO="18" P_CHI2="1.7115664015909804E-4" P_Q="1.0" P_Z="0.1959026868478299" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1270" TOTAL_2="1267" WEIGHT="100.00000000000001" Z="1.2933134032002729">
<NAME>restenosis/occlusion worst</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1660848253289386" CI_START="0.4240733653996223" EFFECT_SIZE="0.7032108618463411" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="37" LOG_CI_END="0.06673014376119621" LOG_CI_START="-0.372559003237565" LOG_EFFECT_SIZE="-0.1529144297381844" ORDER="1" O_E="-5.2879581151832475" SE="0.25804061946342016" STUDY_ID="STD-EVEREST-1998" TOTAL_1="664" TOTAL_2="673" VAR="15.01840626742458" WEIGHT="53.57028771928725"/>
<DICH_DATA CI_END="0.5000990628452455" CI_START="0.03033216010583733" EFFECT_SIZE="0.12316283872581531" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.300943959292604" LOG_CI_START="-1.5180966602913646" LOG_EFFECT_SIZE="-0.9095203097919843" ORDER="2" O_E="-4.096969696969697" SE="0.7149615215697118" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="161" VAR="1.9562964265478773" WEIGHT="6.978061491231367"/>
<DICH_DATA CI_END="4.863528727593203" CI_START="1.214883525165058" EFFECT_SIZE="2.430765501919089" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="10" LOG_CI_END="0.686951485483087" LOG_CI_START="0.0845346427056373" LOG_EFFECT_SIZE="0.3857430640943622" ORDER="3" O_E="7.093235831809871" SE="0.35386263545893903" STUDY_ID="STD-Balzer-1998" TOTAL_1="272" TOTAL_2="275" VAR="7.986023514968166" WEIGHT="28.485950493813725"/>
<DICH_DATA CI_END="4.60153072123469" CI_START="0.04842791290881962" EFFECT_SIZE="0.47206199700379553" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6629023258558219" LOG_CI_START="-1.314904247280414" LOG_EFFECT_SIZE="-0.32600096071229606" ORDER="4" O_E="-0.5561497326203209" SE="1.161773371360658" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="97" TOTAL_2="90" VAR="0.7408958533779688" WEIGHT="2.642757382424364"/>
<DICH_DATA CI_END="0.6497366855305041" CI_START="0.04991751522897936" EFFECT_SIZE="0.18009231214795235" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.18726261134196" LOG_CI_START="-1.3017470408977605" LOG_EFFECT_SIZE="-0.7445048261198604" ORDER="5" O_E="-4.0" SE="0.6546536707079772" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="2.333333333333333" WEIGHT="8.322942913243304"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.126423045981749" CI_END="0.7179078709193851" CI_START="0.3199056956213794" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4792314856502328" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="66" I2="56.171218670811555" I2_Q="75.60489473225581" ID="CMP-001.19" LOG_CI_END="-0.143931285170706" LOG_CI_START="-0.4949780276404441" LOG_EFFECT_SIZE="-0.3194546564055751" METHOD="PETO" NO="19" P_CHI2="0.05801611120693895" P_Q="0.04290404641413037" P_Z="3.608737245954371E-4" Q="4.099182967339865" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1290" TOTAL_2="1267" WEIGHT="100.0" Z="3.5671581330940247">
<NAME>restenosis quality blinding</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.027240078641884" CI_END="0.6077635403805315" CI_START="0.24404775427164702" DF="3.0" EFFECT_SIZE="0.38512767643737855" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="56" I2="40.32510974072171" ID="CMP-001.19.01" LOG_CI_END="-0.21626535671820762" LOG_CI_START="-0.6125251843685291" LOG_EFFECT_SIZE="-0.41439527054336844" NO="1" P_CHI2="0.1698135078821733" P_Z="4.143487381466458E-5" STUDIES="4" TAU2="0.0" TOTAL_1="1005" TOTAL_2="992" WEIGHT="78.48195305708643" Z="4.099329525502433">
<NAME>adequate blinding</NAME>
<DICH_DATA CI_END="0.8760638050827154" CI_START="0.30056335242181986" EFFECT_SIZE="0.5131400142174422" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" LOG_CI_END="-0.05746426234079143" LOG_CI_START="-0.5220639738863216" LOG_EFFECT_SIZE="-0.28976411811355646" ORDER="1" O_E="-8.958333333333332" SE="0.27290817036750736" STUDY_ID="STD-EVEREST-1998" TOTAL_1="671" TOTAL_2="673" VAR="13.426627006287745" WEIGHT="57.091574856812905"/>
<DICH_DATA CI_END="0.5000990628452455" CI_START="0.03033216010583733" EFFECT_SIZE="0.12316283872581531" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.300943959292604" LOG_CI_START="-1.5180966602913646" LOG_EFFECT_SIZE="-0.9095203097919843" ORDER="2" O_E="-4.096969696969697" SE="0.7149615215697118" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="161" VAR="1.9562964265478773" WEIGHT="8.318399239516355"/>
<DICH_DATA CI_END="0.6497366855305041" CI_START="0.04991751522897936" EFFECT_SIZE="0.18009231214795235" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.18726261134196" LOG_CI_START="-1.3017470408977605" LOG_EFFECT_SIZE="-0.7445048261198604" ORDER="3" O_E="-4.0" SE="0.6546536707079772" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="2.333333333333333" WEIGHT="9.921603884841089"/>
<DICH_DATA CI_END="4.60153072123469" CI_START="0.04842791290881962" EFFECT_SIZE="0.47206199700379553" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6629023258558219" LOG_CI_START="-1.314904247280414" LOG_EFFECT_SIZE="-0.32600096071229606" ORDER="4" O_E="-0.5561497326203209" SE="1.161773371360658" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="97" TOTAL_2="90" VAR="0.7408958533779688" WEIGHT="3.1503750759160756"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5421624167249295" CI_START="0.44507578371173445" DF="0.0" EFFECT_SIZE="1.0636987026157194" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" I2="0.0" ID="CMP-001.19.02" LOG_CI_END="0.4052032938317153" LOG_CI_START="-0.3515660347592037" LOG_EFFECT_SIZE="0.026818629536255783" NO="2" P_CHI2="1.0" P_Z="0.8895168114851209" STUDIES="1" TAU2="0.0" TOTAL_1="285" TOTAL_2="275" WEIGHT="21.518046942913575" Z="0.1389156405259057">
<NAME>unadequate blinding</NAME>
<DICH_DATA CI_END="2.5421624167249295" CI_START="0.44507578371173445" EFFECT_SIZE="1.0636987026157194" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.4052032938317153" LOG_CI_START="-0.3515660347592037" LOG_EFFECT_SIZE="0.026818629536255783" ORDER="1" O_E="0.3125" SE="0.44453004968289817" STUDY_ID="STD-Balzer-1998" TOTAL_1="285" TOTAL_2="275" VAR="5.060550368962432" WEIGHT="21.518046942913575"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.126423045981749" CI_END="0.7179078709193851" CI_START="0.3199056956213794" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4792314856502328" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="66" I2="56.171218670811555" I2_Q="83.87921875088573" ID="CMP-001.20" LOG_CI_END="-0.143931285170706" LOG_CI_START="-0.4949780276404441" LOG_EFFECT_SIZE="-0.3194546564055751" METHOD="PETO" NO="20" P_CHI2="0.05801611120693895" P_Q="0.01275223048655627" P_Z="3.608737245954371E-4" Q="6.203173311187655" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1290" TOTAL_2="1267" WEIGHT="100.0" Z="3.5671581330940247">
<NAME>restenosis sample size</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.9529896135209324" CI_END="0.9882435374340943" CI_START="0.3971239375969313" DF="1.0" EFFECT_SIZE="0.626462420972358" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="47" I2="48.79645067865171" ID="CMP-001.20.01" LOG_CI_END="-0.005136017021307216" LOG_CI_START="-0.40107393400655245" LOG_EFFECT_SIZE="-0.2031049755139298" NO="1" P_CHI2="0.16226534738346543" P_Z="0.0443452755863546" STUDIES="2" TAU2="0.0" TOTAL_1="956" TOTAL_2="948" WEIGHT="78.60962179972648" Z="2.010812402708208">
<NAME>large sample</NAME>
<DICH_DATA CI_END="0.8760638050827154" CI_START="0.30056335242181986" EFFECT_SIZE="0.5131400142174422" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" LOG_CI_END="-0.05746426234079143" LOG_CI_START="-0.5220639738863216" LOG_EFFECT_SIZE="-0.28976411811355646" ORDER="1" O_E="-8.958333333333332" SE="0.27290817036750736" STUDY_ID="STD-EVEREST-1998" TOTAL_1="671" TOTAL_2="673" VAR="13.426627006287745" WEIGHT="57.091574856812905"/>
<DICH_DATA CI_END="2.5421624167249295" CI_START="0.44507578371173445" EFFECT_SIZE="1.0636987026157194" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.4052032938317153" LOG_CI_START="-0.3515660347592037" LOG_EFFECT_SIZE="0.026818629536255783" ORDER="2" O_E="0.3125" SE="0.44453004968289817" STUDY_ID="STD-Balzer-1998" TOTAL_1="285" TOTAL_2="275" VAR="5.060550368962432" WEIGHT="21.518046942913575"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9702601212731619" CI_END="0.42901506804106077" CI_START="0.07472194766468103" DF="2.0" EFFECT_SIZE="0.1790442444244542" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="19" I2="0.0" ID="CMP-001.20.02" LOG_CI_END="-0.36752745408062654" LOG_CI_START="-1.1265518165290391" LOG_EFFECT_SIZE="-0.747039635304833" NO="2" P_CHI2="0.61561717349957" P_Z="1.1430289612088136E-4" STUDIES="3" TAU2="0.0" TOTAL_1="334" TOTAL_2="319" WEIGHT="21.390378200273517" Z="3.858033688137177">
<NAME>small sample size</NAME>
<DICH_DATA CI_END="4.60153072123469" CI_START="0.04842791290881962" EFFECT_SIZE="0.47206199700379553" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6629023258558219" LOG_CI_START="-1.314904247280414" LOG_EFFECT_SIZE="-0.32600096071229606" ORDER="1" O_E="-0.5561497326203209" SE="1.161773371360658" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="97" TOTAL_2="90" VAR="0.7408958533779688" WEIGHT="3.1503750759160756"/>
<DICH_DATA CI_END="0.5000990628452455" CI_START="0.03033216010583733" EFFECT_SIZE="0.12316283872581531" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.300943959292604" LOG_CI_START="-1.5180966602913646" LOG_EFFECT_SIZE="-0.9095203097919843" ORDER="2" O_E="-4.096969696969697" SE="0.7149615215697118" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="161" VAR="1.9562964265478773" WEIGHT="8.318399239516355"/>
<DICH_DATA CI_END="0.6497366855305041" CI_START="0.04991751522897936" EFFECT_SIZE="0.18009231214795235" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.18726261134196" LOG_CI_START="-1.3017470408977605" LOG_EFFECT_SIZE="-0.7445048261198604" ORDER="3" O_E="-4.0" SE="0.6546536707079772" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="2.333333333333333" WEIGHT="9.921603884841089"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.798075222146486" CI_END="1.016245199246142" CI_START="0.19107002492632963" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4406517849177774" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="66" I2="48.70529090768419" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.006998506994907757" LOG_CI_START="-0.7188074397381279" LOG_EFFECT_SIZE="-0.3559044663716101" METHOD="MH" NO="21" P_CHI2="0.09926153974392837" P_Q="0.0" P_Z="0.0545848113559712" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.37642603121357654" TOTALS="YES" TOTAL_1="1290" TOTAL_2="1267" WEIGHT="100.00000000000001" Z="1.9221664941300836">
<NAME>restenosis large vs small trials</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8803235000203237" CI_START="0.285023388056358" DF="0.0" EFFECT_SIZE="0.500911954899685" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" I2="0.0" ID="CMP-001.21.01" LOG_CI_END="-0.055357704604101644" LOG_CI_START="-0.5451195017912431" LOG_EFFECT_SIZE="-0.30023860319767237" NO="1" P_CHI2="1.0" P_Z="0.016259725752939647" STUDIES="1" TAU2="0.0" TOTAL_1="671" TOTAL_2="673" WEIGHT="39.58431723550518" Z="2.403032871962435">
<NAME>large trials</NAME>
<DICH_DATA CI_END="0.8803235000203237" CI_START="0.285023388056358" EFFECT_SIZE="0.500911954899685" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" LOG_CI_END="-0.055357704604101644" LOG_CI_START="-0.5451195017912431" LOG_EFFECT_SIZE="-0.30023860319767237" ORDER="1" O_E="0.0" SE="0.28768850402772256" STUDY_ID="STD-EVEREST-1998" TOTAL_1="671" TOTAL_2="673" VAR="0.08276467534970894" WEIGHT="39.58431723550518"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.088452621625898" CI_END="1.4401455597286759" CI_START="0.06025430510731283" DF="3.0" EFFECT_SIZE="0.2945759154357896" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="29" I2="62.9100874995673" ID="CMP-001.21.02" LOG_CI_END="0.1584063897286811" LOG_CI_START="-1.2200119177563327" LOG_EFFECT_SIZE="-0.5308027640138258" NO="2" P_CHI2="0.04421872760345624" P_Z="0.13117361820674328" STUDIES="4" TAU2="1.573922796084385" TOTAL_1="619" TOTAL_2="594" WEIGHT="60.41568276449483" Z="1.5094899635504484">
<NAME>small trials</NAME>
<DICH_DATA CI_END="0.9306693708565998" CI_START="0.003049187218619567" EFFECT_SIZE="0.05327086586847128" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.03120457886338876" LOG_CI_START="-2.5158159093449504" LOG_EFFECT_SIZE="-1.2735102441041697" ORDER="1" O_E="0.0" SE="1.4594729945493115" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="161" VAR="2.1300614218187346" WEIGHT="7.251881743196801"/>
<DICH_DATA CI_END="2.5466337070944567" CI_START="0.444436285779379" EFFECT_SIZE="1.063868613138686" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.405966483076067" LOG_CI_START="-0.35219049052677714" LOG_EFFECT_SIZE="0.026887996274644905" ORDER="2" O_E="0.0" SE="0.4453451592318565" STUDY_ID="STD-Balzer-1998" TOTAL_1="285" TOTAL_2="275" VAR="0.19833231085124764" WEIGHT="31.625031373875736"/>
<DICH_DATA CI_END="0.7953505384149975" CI_START="0.012036793767344678" EFFECT_SIZE="0.0978441127694859" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.09944142059337545" LOG_CI_START="-1.9194891804026388" LOG_EFFECT_SIZE="-1.0094653004980072" ORDER="3" O_E="0.0" SE="1.0691050634936738" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="1.1429856367878124" WEIGHT="11.963018965167148"/>
<DICH_DATA CI_END="5.143130931986219" CI_START="0.04084466198166921" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.711227580575283" LOG_CI_START="-1.388864693682045" LOG_EFFECT_SIZE="-0.338818556553381" ORDER="4" O_E="0.0" SE="1.2336045975231704" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="97" TOTAL_2="90" VAR="1.5217803030303032" WEIGHT="9.575750682255142"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.12642304598175" CI_END="0.7179078709193851" CI_START="0.3199056956213794" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4792314856502328" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="66" I2="56.17121867081157" I2_Q="73.00670491252855" ID="CMP-001.22" LOG_CI_END="-0.143931285170706" LOG_CI_START="-0.4949780276404441" LOG_EFFECT_SIZE="-0.3194546564055751" METHOD="PETO" MODIFIED="2008-08-20 11:57:08 +0100" MODIFIED_BY="Hazel Fraser" NO="22" P_CHI2="0.05801611120693895" P_Q="0.054262142063063235" P_Z="3.608737245954371E-4" Q="3.7046236732474185" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1290" TOTAL_2="1267" WEIGHT="100.0" Z="3.5671581330940247">
<NAME>restenosis quality of randomisation</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.995263654385283" CI_END="0.6083289145175623" CI_START="0.23970532367616149" DF="2.0" EFFECT_SIZE="0.38186343024175573" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="54" I2="59.96207330829828" ID="CMP-001.22.01" LOG_CI_END="-0.21586154056981408" LOG_CI_START="-0.6203223205032431" LOG_EFFECT_SIZE="-0.4180919305365286" NO="1" P_CHI2="0.0822796887706031" P_Z="5.077352195164186E-5" STUDIES="3" TAU2="0.0" TOTAL_1="908" TOTAL_2="902" WEIGHT="75.33157798117034" Z="4.052037511341853">
<NAME>class A studies (adequate concealment)</NAME>
<DICH_DATA CI_END="0.8760638050827154" CI_START="0.30056335242181986" EFFECT_SIZE="0.5131400142174422" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="37" LOG_CI_END="-0.05746426234079143" LOG_CI_START="-0.5220639738863216" LOG_EFFECT_SIZE="-0.28976411811355646" ORDER="1" O_E="-8.958333333333332" SE="0.27290817036750736" STUDY_ID="STD-EVEREST-1998" TOTAL_1="671" TOTAL_2="673" VAR="13.426627006287745" WEIGHT="57.091574856812905"/>
<DICH_DATA CI_END="0.5000990628452455" CI_START="0.03033216010583733" EFFECT_SIZE="0.12316283872581531" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.300943959292604" LOG_CI_START="-1.5180966602913646" LOG_EFFECT_SIZE="-0.9095203097919843" ORDER="2" O_E="-4.096969696969697" SE="0.7149615215697118" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="161" VAR="1.9562964265478773" WEIGHT="8.318399239516355"/>
<DICH_DATA CI_END="0.6497366855305041" CI_START="0.04991751522897936" EFFECT_SIZE="0.18009231214795235" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.18726261134196" LOG_CI_START="-1.3017470408977605" LOG_EFFECT_SIZE="-0.7445048261198604" ORDER="3" O_E="-4.0" SE="0.6546536707079772" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="2.333333333333333" WEIGHT="9.921603884841089"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.42653571834904924" CI_END="2.1635084809789924" CI_START="0.42497395021880646" DF="1.0" EFFECT_SIZE="0.9588716001079246" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" I2="0.0" ID="CMP-001.22.02" LOG_CI_END="0.33515860197761727" LOG_CI_START="-0.3716376902389992" LOG_EFFECT_SIZE="-0.01823954413069098" NO="2" P_CHI2="0.5136937522153513" P_Z="0.9194254861987615" STUDIES="2" TAU2="0.0" TOTAL_1="382" TOTAL_2="365" WEIGHT="24.668422018829652" Z="0.10115743385826091">
<NAME>class B studies (unadequate concealment)</NAME>
<DICH_DATA CI_END="2.5421624167249295" CI_START="0.44507578371173445" EFFECT_SIZE="1.0636987026157194" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.4052032938317153" LOG_CI_START="-0.3515660347592037" LOG_EFFECT_SIZE="0.026818629536255783" ORDER="1" O_E="0.3125" SE="0.44453004968289817" STUDY_ID="STD-Balzer-1998" TOTAL_1="285" TOTAL_2="275" VAR="5.060550368962432" WEIGHT="21.518046942913575"/>
<DICH_DATA CI_END="4.60153072123469" CI_START="0.04842791290881962" EFFECT_SIZE="0.47206199700379553" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6629023258558219" LOG_CI_START="-1.314904247280414" LOG_EFFECT_SIZE="-0.32600096071229606" ORDER="2" O_E="-0.5561497326203209" SE="1.161773371360658" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="97" TOTAL_2="90" VAR="0.7408958533779688" WEIGHT="3.1503750759160756"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.348512636843215" CI_END="1.4653463714310737" CI_START="0.4764878408610751" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8355954335902054" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="27" I2="54.007262550997396" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="0.16594029323700818" LOG_CI_START="-0.3219481773222249" LOG_EFFECT_SIZE="-0.07800394204260835" METHOD="PETO" NO="23" P_CHI2="0.11369275372642629" P_Q="1.0" P_Z="0.5308422953872889" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1133" TOTAL_2="1105" WEIGHT="100.0" Z="0.6267207621464008">
<NAME>all strokes during follow-up and perioperative deaths</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9486788975018232" CI_START="0.5622799671193793" EFFECT_SIZE="1.0467583801496665" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="20" LOG_CI_END="0.2897402821489402" LOG_CI_START="-0.2500473892355605" LOG_EFFECT_SIZE="0.01984644645668987" ORDER="1" O_E="0.45454545454545325" SE="0.3170739501633224" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="9.946696659983374" WEIGHT="81.69494566548856"/>
<DICH_DATA CI_END="0.8522765566736825" CI_START="0.016509624293617284" EFFECT_SIZE="0.11862025857727806" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.06941945740661325" LOG_CI_START="-1.782262809781749" LOG_EFFECT_SIZE="-0.9258411335941812" ORDER="2" O_E="-2.1059190031152646" SE="1.006132663896492" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="152" VAR="0.9878465853398162" WEIGHT="8.11345473516326"/>
<DICH_DATA CI_END="3.773345924134136" CI_START="0.11180445707191788" EFFECT_SIZE="0.6495205096010066" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5767266212773398" LOG_CI_START="-0.9515408830045508" LOG_EFFECT_SIZE="-0.1874071308636055" ORDER="3" O_E="-0.5354609929078014" SE="0.8977118970613361" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.2408692957555716" WEIGHT="10.191599599348184"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.033446136068126" CI_END="22.082051071019002" CI_START="0.022843154998266654" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.7102279319309591" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="9" I2="80.13289557557182" I2_Q="0.0" ID="CMP-001.24" LOG_CI_END="1.3440394099745137" LOG_CI_START="-1.6412439133985925" LOG_EFFECT_SIZE="-0.14860225171203945" METHOD="MH" NO="24" P_CHI2="0.02486241076462581" P_Q="0.0" P_Z="0.8452933309578601" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="5.050930182926657" TOTALS="YES" TOTAL_1="847" TOTAL_2="827" WEIGHT="100.0" Z="0.19512724912693413">
<NAME>ipsilateral stroke during follow-up and perioperative deaths</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.388946030828967" CI_START="1.0956142131030195" EFFECT_SIZE="3.0316742081447963" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.9237074004296338" LOG_CI_START="0.039657657601797576" LOG_EFFECT_SIZE="0.48168252901571573" ORDER="1" O_E="0.0" SE="0.5192951950538751" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="0.2696674996060422" WEIGHT="57.79441775544602"/>
<DICH_DATA CI_END="1.823108087644643" CI_START="0.005197758121442763" EFFECT_SIZE="0.09734513274336283" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2608124176818925" LOG_CI_START="-2.284183934332282" LOG_EFFECT_SIZE="-1.0116857583251946" ORDER="2" O_E="0.0" SE="1.4949434551082454" STUDY_ID="STD-Ballotta-1999" TOTAL_1="169" TOTAL_2="152" VAR="2.2348559339709784" WEIGHT="42.20558224455399"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.639511915407859" CI_END="1.285425716624958" CI_START="0.18936318434836247" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.493368327868113" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="39" I2="54.81595577774164" I2_Q="0.0" ID="CMP-001.25" LOG_CI_END="0.10904698429119355" LOG_CI_START="-0.7227044518824467" LOG_EFFECT_SIZE="-0.3068287337956266" METHOD="MH" NO="25" P_CHI2="0.08431996537244835" P_Q="0.0" P_Z="0.14816575071992533" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.48941375432847567" TOTALS="YES" TOTAL_1="1292" TOTAL_2="1271" WEIGHT="100.00000000000001" Z="1.4460408278415293">
<NAME>perioperative stroke and/or death (separate analysis)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2848152653922003" CI_START="0.5604658880513462" EFFECT_SIZE="1.1316187594553706" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.3588510917301181" LOG_CI_START="-0.2514508149724759" LOG_EFFECT_SIZE="0.05370013837882111" ORDER="1" O_E="0.0" SE="0.35849436104026466" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="0.12851820689766763" WEIGHT="38.62972923960183"/>
<DICH_DATA CI_END="1.081028319585187" CI_START="0.003464558222748349" EFFECT_SIZE="0.061198738170347" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.03383707126920008" LOG_CI_START="-2.460352135844251" LOG_EFFECT_SIZE="-1.2132575322875254" ORDER="2" O_E="0.0" SE="1.4650990866941371" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="2.1465153338319944" WEIGHT="9.055837070078596"/>
<DICH_DATA CI_END="1.5770599185928242" CI_START="0.13369792960623703" EFFECT_SIZE="0.45918367346938777" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.19784819416585697" LOG_CI_START="-0.8738753180001593" LOG_EFFECT_SIZE="-0.33801356191715115" ORDER="3" O_E="0.0" SE="0.629535696163263" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="102" TOTAL_2="98" VAR="0.3963151927437642" WEIGHT="26.950168479381514"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1828308145400106" CI_START="0.08487241295006054" EFFECT_SIZE="0.3168433451118963" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.07292263003261329" LOG_CI_START="-1.0712334505157026" LOG_EFFECT_SIZE="-0.49915541024154475" ORDER="5" O_E="0.0" SE="0.6720829453780219" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="0.4516954854679972" WEIGHT="25.364265210938072"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.172092417024021" CI_END="6.445203349966508" CI_START="0.7265976475492565" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.164040108699987" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" I2="53.96144325340918" I2_Q="0.0" ID="CMP-001.26" LOG_CI_END="0.8092366241525962" LOG_CI_START="-0.13870601255372075" LOG_EFFECT_SIZE="0.33526530579943775" METHOD="PETO" NO="26" P_CHI2="0.14053497666483894" P_Q="1.0" P_Z="0.16562860258325804" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="998" TOTAL_2="985" WEIGHT="100.0" Z="1.3863875285024974">
<NAME>ipsilateral stroke during follow-up (separate analysis)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.550564418979913" CI_START="0.881179847975659" EFFECT_SIZE="2.7449198630966984" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="0.9319947832612738" LOG_CI_START="-0.05493544344710418" LOG_EFFECT_SIZE="0.43852966990708475" ORDER="1" O_E="3.0044609665427506" SE="0.5797277005519138" STUDY_ID="STD-EVEREST-1998" TOTAL_1="672" TOTAL_2="673" VAR="2.9754447837923745" WEIGHT="92.25527639171416"/>
<DICH_DATA CI_END="6.431519433779347" CI_START="0.00252373285123211" EFFECT_SIZE="0.12740265648080762" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8083135862604542" LOG_CI_START="-2.5979566190698273" LOG_EFFECT_SIZE="-0.8948215164046867" ORDER="2" O_E="-0.5146579804560261" SE="2.0008599799204596" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="149" VAR="0.24978514360895077" WEIGHT="7.744723608285842"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="100" TOTAL_2="95" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.033100976785887" CI_END="1.6379909941360542" CI_START="0.4287590728665579" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8380355004470551" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="19" I2="1.6281029404754916" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="0.2143115096296692" LOG_CI_START="-0.36778667685193456" LOG_EFFECT_SIZE="-0.07673758361113267" METHOD="PETO" NO="27" P_CHI2="0.3618410938146097" P_Q="1.0" P_Z="0.6053228188194839" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1215" TOTAL_2="1192" WEIGHT="100.0" Z="0.5167612737209734">
<NAME>stroke during follow-up (separate analysis)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6585005691982" CI_START="0.41670649399355075" EFFECT_SIZE="0.8313290308156513" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.21971562490560356" LOG_CI_START="-0.38016973140356064" LOG_EFFECT_SIZE="-0.08022705324897852" ORDER="1" O_E="-1.4877323420074333" SE="0.352375627776408" STUDY_ID="STD-EVEREST-1998" TOTAL_1="672" TOTAL_2="673" VAR="8.053566976686337" WEIGHT="94.15772816766393"/>
<DICH_DATA CI_END="6.431519433779347" CI_START="0.00252373285123211" EFFECT_SIZE="0.12740265648080762" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8083135862604542" LOG_CI_START="-2.5979566190698273" LOG_EFFECT_SIZE="-0.8948215164046867" ORDER="2" O_E="-0.5146579804560261" SE="2.0008599799204596" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="149" VAR="0.24978514360895077" WEIGHT="2.920345943646641"/>
<DICH_DATA CI_END="359.77016168908744" CI_START="0.14147378750062387" EFFECT_SIZE="7.134286748082604" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.556025141357673" LOG_CI_START="-0.8493240194922624" LOG_EFFECT_SIZE="0.8533505609327054" ORDER="3" O_E="0.4910714285714286" SE="2.0003189538334607" STUDY_ID="STD-Balzer-1998" TOTAL_1="285" TOTAL_2="275" VAR="0.2499202806122449" WEIGHT="2.921925888689427"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="100" TOTAL_2="95" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.202442358495332" CI_END="1.1732657518303438" CI_START="0.27798177349327247" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5710923694751284" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="19" I2="6.3214989009341505" I2_Q="0.0" ID="CMP-001.28" LOG_CI_END="0.0693963936001309" LOG_CI_START="-0.5559836786531286" LOG_EFFECT_SIZE="-0.2432936425264989" METHOD="PETO" NO="28" P_CHI2="0.3614533199505279" P_Q="1.0" P_Z="0.1272635072885675" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1292" TOTAL_2="1271" WEIGHT="100.00000000000001" Z="1.5249823209153752">
<NAME>perioperative disabling stroke (separate analysis)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.852634944629901" CI_START="0.3474277875098505" EFFECT_SIZE="0.9955323437166927" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4552461979883864" LOG_CI_START="-0.459135449332849" LOG_EFFECT_SIZE="-0.0019446256722313194" ORDER="1" O_E="-0.015521064301552201" SE="0.5371123058986466" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="3.4663291119134505" WEIGHT="46.77707647090544"/>
<DICH_DATA CI_END="1.243831628420941" CI_START="0.013250540251608099" EFFECT_SIZE="0.12838006488008538" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.09476159595237413" LOG_CI_START="-1.8777664142925292" LOG_EFFECT_SIZE="-0.8915024091700774" ORDER="2" O_E="-1.5290322580645161" SE="1.1586727173889815" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="0.7448664922259377" WEIGHT="10.05175092801106"/>
<DICH_DATA CI_END="1.4236380921082472" CI_START="0.0874868744936854" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" ORDER="3" O_E="-2.0567375886524824" SE="0.7116156614479168" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.9747358237999224" WEIGHT="26.64847037237468"/>
<DICH_DATA CI_END="3.7512260359218064" CI_START="0.10855553693883893" EFFECT_SIZE="0.6381350613376795" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5741732340243342" LOG_CI_START="-0.9643480201998168" LOG_EFFECT_SIZE="-0.19508739308774134" ORDER="4" O_E="-0.5499999999999998" SE="0.9037350005343009" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="102" TOTAL_2="98" VAR="1.2243844221105527" WEIGHT="16.522702228708834"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="5" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.063969541742271" CI_END="1.0935174800370795" CI_START="0.3526352798450201" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6209773285622404" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="30" I2="57.53096071164437" I2_Q="0.0" ID="CMP-001.29" LOG_CI_END="0.03882572969004478" LOG_CI_START="-0.452674240319333" LOG_EFFECT_SIZE="-0.2069242553146441" METHOD="PETO" NO="29" P_CHI2="0.06988664861721983" P_Q="1.0" P_Z="0.09887919017423712" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1292" TOTAL_2="1271" WEIGHT="99.99999999999997" Z="1.6503117505245635">
<NAME>perioperative stroke (separate analysis)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4340394542985435" CI_START="0.5449483076429672" EFFECT_SIZE="1.151705553236678" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.38632761360040274" LOG_CI_START="-0.26364469179701283" LOG_EFFECT_SIZE="0.061341460901694914" ORDER="1" O_E="0.9689578713968956" SE="0.3817969496052434" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="6.860173373092341" WEIGHT="57.181729516971195"/>
<DICH_DATA CI_END="0.7397912160775231" CI_START="0.021686735185707032" EFFECT_SIZE="0.12666355512058475" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.13089082959227746" LOG_CI_START="-1.6638058236222386" LOG_EFFECT_SIZE="-0.8973483266072582" ORDER="2" O_E="-2.5483870967741935" SE="0.9004418555447982" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="1.2333565696466398" WEIGHT="10.280419739847337"/>
<DICH_DATA CI_END="1.4236380921082472" CI_START="0.0874868744936854" EFFECT_SIZE="0.3529159207073322" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15339959985097923" LOG_CI_START="-1.0580570985496753" LOG_EFFECT_SIZE="-0.45232874934934797" ORDER="3" O_E="-2.0567375886524824" SE="0.7116156614479168" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="1.9747358237999224" WEIGHT="16.460051897070404"/>
<DICH_DATA CI_END="1.3949740290841226" CI_START="0.08294547542085534" EFFECT_SIZE="0.34015699910795405" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.1445661222114454" LOG_CI_START="-1.081207299252022" LOG_EFFECT_SIZE="-0.4683205885202883" ORDER="4" O_E="-2.08" SE="0.7200253754439353" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="102" TOTAL_2="98" VAR="1.9288763819095478" WEIGHT="16.07779884611105"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="5" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.190290227880311" CI_END="1.925688201510575" CI_START="0.33088116476298035" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7982317677755928" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" I2="51.5370057047024" I2_Q="0.0" ID="CMP-001.30" LOG_CI_END="0.28458596953539944" LOG_CI_START="-0.4803279541224703" LOG_EFFECT_SIZE="-0.09787099229353541" METHOD="PETO" NO="30" P_CHI2="0.10271050453199493" P_Q="1.0" P_Z="0.6159798121939752" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1292" TOTAL_2="1271" WEIGHT="100.0" Z="0.5015560943359827">
<NAME>perioperative death (separate analysis)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="10.916339599418276" CI_START="0.6778987832773289" EFFECT_SIZE="2.7203259606686423" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.0380770377947899" LOG_CI_START="-0.1688351455807718" LOG_EFFECT_SIZE="0.43462094610700897" ORDER="1" O_E="1.9911308203991132" SE="0.7089461908264649" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="1.9896351885302852" WEIGHT="40.16740637665813"/>
<DICH_DATA CI_END="1.243831628420941" CI_START="0.013250540251608099" EFFECT_SIZE="0.12838006488008538" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.09476159595237413" LOG_CI_START="-1.8777664142925292" LOG_EFFECT_SIZE="-0.8915024091700774" ORDER="2" O_E="-1.5290322580645161" SE="1.1586727173889815" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="0.7448664922259377" WEIGHT="15.037608533500102"/>
<DICH_DATA CI_END="2.5378534734608977" CI_START="0.0498124378291256" EFFECT_SIZE="0.35555121764128644" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4044665438798851" LOG_CI_START="-1.302662203302162" LOG_EFFECT_SIZE="-0.44909782971113843" ORDER="3" O_E="-1.0283687943262412" SE="1.0027758765183197" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="0.9944712781726227" WEIGHT="20.076711645706972"/>
<DICH_DATA CI_END="3.7512260359218064" CI_START="0.10855553693883893" EFFECT_SIZE="0.6381350613376795" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5741732340243342" LOG_CI_START="-0.9643480201998168" LOG_EFFECT_SIZE="-0.19508739308774134" ORDER="4" O_E="-0.5499999999999998" SE="0.9037350005343009" STUDY_ID="STD-Vanmaele-1994" TOTAL_1="102" TOTAL_2="98" VAR="1.2243844221105527" WEIGHT="24.7182734441348"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="5" O_E="0.0" SE="0.0" STUDY_ID="STD-Ballotta-2000" TOTAL_1="68" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.2113025902420675" CI_END="1.8168993201781227" CI_START="0.10447169114227907" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.43567711050073044" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" I2="67.80063487581506" I2_Q="0.0" ID="CMP-001.31" LOG_CI_END="0.25933086241947306" LOG_CI_START="-0.9810013750673822" LOG_EFFECT_SIZE="-0.3608352563239545" METHOD="MH" NO="31" P_CHI2="0.04479536939717166" P_Q="0.0" P_Z="0.2541286662340979" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="1.0065879681603114" TOTALS="YES" TOTAL_1="1122" TOTAL_2="1105" WEIGHT="100.0" Z="1.140378497587385">
<NAME>perioperative stroke and/or death (separate analysis. 2)</NAME>
<GROUP_LABEL_1>Eversion</GROUP_LABEL_1>
<GROUP_LABEL_2>Conventional</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours eversion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours conventional</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.081028319585187" CI_START="0.003464558222748349" EFFECT_SIZE="0.061198738170347" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.03383707126920008" LOG_CI_START="-2.460352135844251" LOG_EFFECT_SIZE="-1.2132575322875254" ORDER="1" O_E="0.0" SE="1.4650990866941371" STUDY_ID="STD-Ballotta-1999" TOTAL_1="158" TOTAL_2="152" VAR="2.1465153338319944" WEIGHT="16.83499795184227"/>
<DICH_DATA CI_END="1.1828308145400106" CI_START="0.08487241295006054" EFFECT_SIZE="0.3168433451118963" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.07292263003261329" LOG_CI_START="-1.0712334505157026" LOG_EFFECT_SIZE="-0.49915541024154475" ORDER="2" O_E="0.0" SE="0.6720829453780219" STUDY_ID="STD-Balzer-1998" TOTAL_1="286" TOTAL_2="278" VAR="0.4516954854679972" WEIGHT="36.400665110006365"/>
<DICH_DATA CI_END="2.2848152653922003" CI_START="0.5604658880513462" EFFECT_SIZE="1.1316187594553706" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.3588510917301181" LOG_CI_START="-0.2514508149724759" LOG_EFFECT_SIZE="0.05370013837882111" ORDER="3" O_E="0.0" SE="0.35849436104026466" STUDY_ID="STD-EVEREST-1998" TOTAL_1="678" TOTAL_2="675" VAR="0.12851820689766763" WEIGHT="46.76433693815137"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-08-19 15:49:41 +0100" MODIFIED_BY="Hazel Fraser">
<APPENDIX ID="APP-01" MODIFIED="2008-08-19 15:49:34 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<TITLE MODIFIED="2008-08-19 15:49:21 +0100" MODIFIED_BY="Hazel Fraser">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-19 15:49:34 +0100" MODIFIED_BY="Hazel Fraser">
<P>MEDLINE (Ovid) and the Cochrane Central Register of Controlled Trials</P>
<P>1 exp carotid arteries/<BR/>2 exp carotid artery diseases/<BR/>3 endarterectomy, carotid/<BR/>4 carotid.tw<BR/>5 endarterectomy/ or endarterectomy.tw or surgery.tw<BR/>6 4 and 5<BR/>7 1 or 2 or 3 or 6<BR/>8 eversion.tw<BR/>9 7 and 8</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-08-19 15:49:41 +0100" MODIFIED_BY="Hazel Fraser" NO="2">
<TITLE MODIFIED="2008-08-19 15:49:27 +0100" MODIFIED_BY="Hazel Fraser">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-19 15:49:41 +0100" MODIFIED_BY="Hazel Fraser">
<P>EMBASE (Ovid)</P>
<P>1 exp carotid artery/<BR/>2 exp carotid artery disease/<BR/>3 carotid artery surgery/<BR/>4 carotid endarterectomy/<BR/>5 carotid.tw<BR/>6 endarterectomy/ or endarterectomy.tw or surgery.tw or su.fs<BR/>7 5 and 6<BR/>8 1 or 2 or 3 or 4 or 7<BR/>9 eversion.tw<BR/>10 8 and 9</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>